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ABSTRACT
Genetic and environmental factors contribute to variation in tuberculosis (TB)
disease risk among individuals in the Americas, although the relative contribution of
each of these factors remains unclear. Genetic ancestry may serve as a proxy for
underlying genetic differences in TB risk between the European, Native American, and
African groups that formed many populations in the Americas, but this has never been
tested. Such tests are complicated by the fact that genetic ancestry and important
potential social predictors of TB are usually confounded. The urban center of Nuevo
León, the Monterrey Metropolitan Area (MMA), presents a unique setting to tease
apart these predictors. The MMA has excessive rates of TB disease and drug-resistant
TB, and it is heterogeneous with respect to potential social predictors of disease risk
and genetic ancestry.
This dissertation addressed three aims. First, we explored predictors of active TB
in the MMA, including genetic ancestry, demographic, and socioeconomic
characteristics. Second, we assessed the variability of genetic ancestry in the MMA to
determine whether genetic ancestry could potentially capture genetic variants
underlying disease risk in the parental populations. Third, we examined social and
behavioral predictors of drug-resistant TB in the MMA. Data included detailed
demographic and socioeconomic measures and 291,917 genetic markers from 194
individuals with latent TB infection and active pulmonary TB at the University Hospital
in Monterrey.
We found that diabetes, computer ownership, and marital status predicted
active TB. Substantial variation in genetic ancestry was observed, but genetic ancestry
was not a risk factor for active TB after controlling for socioeconomic variables. This
result indicates that: 1) genetic components of TB disease risk do not vary in the
parental populations that formed the MMA, 2) effects of genetic factors are low
vi

compared to social factors, or 3) power was too low to detect existing associations.
Finally, we found that crack cocaine use predicted drug-resistant TB in this urban
context. In conclusion, variation in TB rates across populations may be better
understood by addressing population-specific social factors that have larger effects on
active TB and drug-resistant TB susceptibility.
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“Why should tuberculosis flow such a malignant course in one person while sparing
another? Chance, timing, circumstance, age at exposure, duration and severity of
exposure, natural powers of resistance – all of these and more are known to play some
part. But often there is no apparent reason: it is simply a mystery.”

Frank Ryan, The Forgotten Plague: How the Battle against Tuberculosis was Won – and
Lost
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CHAPTER 1. INTRODUCTION

PURPOSE
Multifactorial diseases show remarkable variation across racial and ethnic
groups due to a complex suite of risk factors. Host genetics, co-morbidities, and
biological characteristics are contributing individual-level factors, but broader
contextual issues, such as healthcare access, socioeconomic inequalities, political
structures, and cultural landscapes, are major drivers of health disparities [1, 2].
Tuberculosis disease (TB) presents a unique opportunity to investigate these complex
risk factors. Throughout the Americas, lower rates of TB disease are seen among people
of European descent, while higher rates persist among people of Native American,
Asian, and African descent. These TB disparities are largely attributed to social
determinants that differentially increase exposure to environmental risk factors among
those with lower proportions of European ancestry [3, 4]. TB disease disparities may
further be explained by genetic factors that affect immune responses to
Mycobacterium tuberculosis; however, it is unclear if genetic variants for susceptibility
and resistance show significant differences across continental regions. Among
populations of mixed descent, genetic ancestry may therefore influence TB disease risk
through its association with social determinants, or possibly through its association with
predisposing TB-risk alleles that differ in frequencies between parental populations.
Admixed populations provide the opportunity to assess the role of genetic and
environmental factors in explaining observed differences in TB disease rates between
populations.
Inhabitants of Mexico are an admixed population with genetic contributions
from European, Native American, and African ancestral populations. Variation in TB
rates in Mexico, as well as other places throughout the Americas, has long been
assumed to be partially due to genetic risk factors that differ between these parental
groups. It is unknown if continental genetic ancestry predicts TB disease risk after taking
into account key social determinants. Teasing apart the contributing risk factors for TB
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disease is crucial for guiding public health prevention strategies. The purpose of this
dissertation is to identify the sociocultural risk factors for active TB and drug-resistant
TB (DRTB), and to investigate if continental genetic ancestry in admixed populations has
the potential to capture the genetic differences underlying TB disease risk in the
parental populations.

BACKGROUND
TB is one of the oldest known diseases in human history [5]. TB remains a major
cause of morbidity in developing countries, and it is second only to HIV as a leading
cause of death by infectious disease worldwide [6]. TB is spread through the air from
human-to-human by aerosolized droplet nuclei containing the pathogen,
Mycobacterium tuberculosis [7, 8]. In 2010, there were approximately 8.8 million new
and relapse cases and 1.4 million deaths from TB disease [6]. The immune system of the
majority of people who become infected with TB neutralizes the bacterium in the lungs,
preventing its spread to other individuals, and permanently containing the infection in a
state of subclinical latency [9]. Approximately 10% of infected individuals develop active
disease, with 5% developing active disease during the first two years after infection, and
5% at a later point in life [9].
Rates of active TB vary substantially across racial and ethnic groups, as seen with
Figure 1.1. This figure from the Centers for Disease Control and Prevention (CDC) shows
clear differences in case rates in the United States from 1993 to 2009 [10]. Although
rates show overall declines in all sub-groups, they are consistently lowest among
Whites.
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Active TB Case Rates by Race/Ethnicity, United States, 1993-2009

Figure 1.1. Active TB rates by race and ethnicity in the United States, 1993-2009. Taken
from CDC 2011 [10].

Lower TB rates among people of western European descent is a common
pattern in other areas of the world, as well [6]. This racial and ethnic variation is largely
structured by environmental factors, such as sociocultural, economic, and political
conditions that predispose an individual to developing active disease [3, 4, 11, 12]. Host
genetics have also been shown to play a role in immunological susceptibility and
resistance [13-15], although it is less clear if genetic variants differ among the
continental groups that contributed to the admixed groups in the Americas [16].
Continental genetic ancestry is increasingly used in biomedical studies to
investigate disease disparities. This approach assumes that the genetic component of
disease risk is in fact structured by continental origins. To date, no study has assessed if
genetic ancestry is independently associated with active TB. Furthermore, underlying
environmental causes are mostly indicators of poverty and socioeconomic inequalities,
but given the wide variation of these factors in different contexts, it is imperative to
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explore population-specific environmental predictors of TB disease. This is the first
study to integrate data on genetic ancestry, individual-level, and social variables.
DRTB is a unique problem for TB prevention and treatment efforts as cases with
drug resistance have lower cure rates than cases with drug sensitivity [17, 18]. Treating
DRTB costs 50 to 200 times more, and the duration of treatment is three to four times
longer. In some areas of the world, including Mexico, rates of DRTB are increasing [19].
Pertinent risk factors for DRTB vary across populations, and it can be difficult to identify
main predictors of risk for drug resistance based on patient-related factors that
increase vulnerability. Among urban populations in Mexico where drug resistance is
especially problematic, particularly among the U.S.-Mexico Border States, it is necessary
to identify the main correlates of drug resistance in order to identify patient predictors
of increased risk at clinic visits.
This dissertation combines anthropological and epidemiological perspectives to
explore the effects of genetic ancestry and environmental factors on active pulmonary
TB and DRTB, in an urban population of the Monterrey Metropolitan Area (MMA) in
Nuevo León, Mexico. Urban areas typically have higher rates of TB compared to rural
areas, partly due to greater residential crowding and higher likelihood of close contact
with an active case [20]. Urbanized centers also tend to house extremes in wealth and
poverty [21], and it is in pockets of severe poverty that TB thrives [12, 20]. There is the
need to identify risk factors for active TB and DRTB in these contexts given increasing
urbanization in developing countries.
To achieve this broad goal, we conducted research in the MMA and examined:
1) the independent contributions of population-specific sociocultural factors and
genetic ancestry to active TB status; 2) the evolutionary history that produced the
current pattern of genetic ancestry in the MMA; and 3) the independent predictors of
DRTB.
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RESEARCH DESIGN
Study population
TB disease rates have remained relatively stable in Mexico since 1990, with 16.8
new TB cases per 100,000 in 2010 [22], although increasing rates of drug-resistant TB
(DRTB) greatly hinder control efforts [23]. The state of Nuevo León has almost double
the rates of TB disease and mortality compared to national averages, despite its relative
affluence [24]. The urban center of Nuevo León, the Monterrey Metropolitan Area
(MMA), presents a unique population for this study given variation in previously
reported genetic ancestry estimates [25-28], socioeconomic imbalances throughout the
area [29, 30], and excessive rates of active pulmonary TB and DRTB [22, 31].
Approximately 90% of TB cases in Nuevo León occur in the MMA [32], located
140 miles southeast of Laredo, Texas (Figure 1.2). The MMA is comprised of nine
municipalities totaling approximately 3.9 million inhabitants, making it the third largest
population center in Mexico, after Mexico City and Guadalajara [33]. The nine
municipalities include Apodaca, Escobedo, García, Guadalupe, Juárez, Monterrey, San
Nicolás de la Garza, San Pedro, and Santa Catarina. Its strong industrial and business
sectors make it one of the wealthiest and most developed cities in Mexico, well-known
for its production of steel, cement, processed food and soda products, beer, glass, and
auto parts. An industrial boom in the 1940s led to massive migrations to the MMA [25],
and today, the vast majority of Nuevo León’s population (90% as of 2009) lives in this
urbanized center [34]. The quick expansion of the area lead to disproportionate
economic development [29, 30]; today, the MMA contains one of the richest
municipalities in Latin America (San Pedro) but also several severely disadvantaged
sections (e.g., Colonia Independencia).
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Figure 1.2. Study area in the Monterrey Metropolitan Area (red) in Nuevo León, Mexico

Brief overview of field site and recruitment
This dissertation research was conducted at the Hospital “Jose E. Gonzalez” of
the Autonomous University of Nuevo León (UANL), in Monterrey, from January 2010 to
February 2011. The University Hospital is a 500-bed teaching, research, and assistance
facility that serves low to low-middle socioeconomic status individuals in Monterrey.
The majority of patients at the hospital are residents of Monterrey or surrounding
municipalities. The University Hospital treats approximately one quarter of all new TB
cases in the region [35].
The overall study design was a case-control study. A total of 194 people were
recruited. Cases (n=97) were comprised of individuals with bacteriologically confirmed
active pulmonary TB who came to the TB clinic in the Hospital for diagnosis, treatment,
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or follow-up. Controls (n=97) had latent TB infection as confirmed by a skin test (PPD);
cut-off for enrollment was ≥10 millimeters [36]. Controls were recruited from the
Internal Medicine clinic, hospital personnel, and people in waiting rooms. Additional
details of the sample are provided in each chapter.

GUIDE TO THE DISSERTATION
The dissertation is organized by three chapters written for peer-review
publications. Chapter 2 formally tests the association between genetic ancestry and
active TB status, and explores individual and social variables that are important
predictors of active TB in this sample. We intend to submit Chapter 2 as an original
research article to the International Journal of Tuberculosis and Lung Disease. Chapter 3
investigates the distribution of European, Native American, and African ancestry
estimates in the sample, and assesses the potential to use ancestry as an indicator of
the differences in genetic risk among the parental populations that contributed to the
admixed group. We plan to submit Chapter 3 as an original research article to the
American Journal of Physical Anthropology. Chapter 4 presents an exploratory analysis
of the predictors of DRTB in the sample, with clinical implications for identifying TB
patients at greater risk for drug resistance. Chapter 4 for will be submitted as a brief
communication to the Pan American Journal of Public Health. A summary of the findings
and key conclusions from each chapter is presented in chapter 5.
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CHAPTER 2. INDIVIDUAL AND SOCIAL CORRELATES OF ACTIVE TB:
DIABETES, COMPUTER OWNERSHIP, AND MARITAL STATUS

INTRODUCTION
The main cause for transition from latent TB infection to active TB disease is
immune incapacity of the host, which can be affected by genetic factors, age, sex, and
medical conditions that suppress immunity, such as HIV/AIDS, malnutrition, diabetes
mellitus, heavy smoking, silicosis, malignancies, and immune-suppressive treatment [9,
13, 14]. These individual risk factors are in turn influenced by a wide range of social,
political, and economic conditions that vary substantially within and among regions [3,
4, 11, 12, 37]. Growing awareness of these conditions in the 20 th century led to
substantial progress in the fight against TB in both developed and developing nations
[4], but that progress has slowed in recent years in some Latin American countries.
Mexico, for example, initiated environmental, dietetic, and hygienic programs
that led to substantial declines in TB rates even before the widespread use of anti-TB
medications starting in 1947, and the development of the bacille Calmette-Guérin (BCG)
vaccination in 1948 [38]. As a result of these public programs, TB morbidity was halved
from approximately 80 cases per 100,000 in 1920 to 41 cases per 100,00 by 1950 [38].
Anti-TB medication use and BCG vaccinations led to further declines in TB rates, to 16
cases per 100,000 in 1970 [38], but this promising trend ceased in the 1980s [19, 39,
40]. Rates have remained relatively stable since, with 16 (14-19) new TB cases per
100,000 in 2010 [22, 23, 41]. This rate contrasts with 4.1 (3.6-4.7) new cases per
100,000 in the United States in 2010 [41].
Within Mexico, there is substantial variation in TB rates across regions, but
contrary to trends in the US [3, 37], the variation is not as clearly related to
conventional socioeconomic measures. Nuevo León, for example, is one of the
wealthiest of the 32 federal entities in Mexico as measured by living conditions,
material possessions, education, employment, and infant mortality [42], yet in 2010, it
ranked 9th highest in the country for TB incidence, at 24.2 new cases per 100,000 [22]. It
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ranked 6th highest in the country in TB deaths, at 3.5 per 100,000, almost double the
national average [42], and rates of drug-resistant TB are excessive compared to other
regions [31]. This lack of association with conventional socioeconomic measures
suggests that they might not capture important aspects of the social environment in
developing nations, and, in particular, large urban centers [2, 3, 43].
In addition to social conditions, indigenous ancestry may also explain variation in
TB rates between Mexico and other countries, as well as variation in rates throughout
Mexico [44, 45]. Indigenous peoples tend to suffer disproportionately from TB disease
throughout the Americas [10, 45]. This disparity may reflect underlying genetic
differences between Native Americans and people of European descent [44, 46, 47],
but it may also reflect persistent, wide gaps in socioeconomic status and healthcare
access between these groups [4, 12]. In the Monterrey Metropolitan Area (MMA), the
largest urban center in Nuevo León, estimates of indigenous ancestry range from 3156%, and studies suggest a high European component compared to other regions in
Mexico [25-27, 48, 49]. Given the relatively lower proportions of indigenous ancestry,
higher proportions of European ancestry, and overall wealth of the MMA, it is
paradoxical that TB rates are excessive in this region. Genomic data collected
specifically from latent and active TB patients are required to assess the true levels of
genetic ancestry and the association between genetic ancestry and TB disease status.
Our goal in this study is to identify the contribution of social factors and genetic
ancestry to variation in TB disease status in the MMA. Our data include comprehensive,
region-specific measures of social and environmental conditions, including self-reported
ethnicity and indigenous language ability, and genetic ancestry estimated from 291,917
genomic markers. The results of this study have broader implications for exploring the
social and genetic correlates of TB disease in urban centers in developed and
developing countries.

MATERIALS AND METHODS
Study design and participants
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Between January 2010 and February 2011, we conducted a case-control study at
the Universidad Autónoma de Nuevo León (UANL) Hospital Jose E. Gonzalez in
Monterrey. Every year, the hospital treats approximately one quarter of the new TB
cases in the MMA [35]. The hospital is located in Monterrey, which is a moderate to low
socioeconomic status municipality in the MMA [29, 50], and its open-door policy of
treating patients independent of insurance status or income pulls in residents from all
municipalities.
We recruited cases from adult patients at the hospital who currently had active
pulmonary TB or had ever been diagnosed with active pulmonary TB (n = 97), as
confirmed through the Mexican Ministry of Health’s guidelines of bacteriological smear,
culture, or histopathology [51]. Patients with extrapulmonary TB were not eligible for
enrollment. Our control group was adults with latent TB infection, identified by a
positive TB skin test (purified protein derivative test, PPD) of ≥10 millimeters [36, 52].
Controls had no history of transitioning to active disease, and we carefully selected
them be representative of the population at risk for active disease based on known TB
risk factors, such as sex, age, and low income. Our careful selection of controls that
represented similar risk exposures as cases was done in an attempt to limit selection
bias so that the study groups were comparable populations. Controls were recruited
from the Hospital’s Center of Research, Prevention, and Treatment of Respiratory
Infections (CIPTIR), the Internal Medicine Clinic, and other clinic’s waiting rooms within
the hospital (n = 40). Individuals with diagnosed HIV were excluded from the study due
to the strongly inflated risk of developing active TB and immunological anergy that
could result in a false-negative PPD test [9]. The study was approved by the University
of New Mexico (UNM) and UANL Institutional Review Boards, and all participants gave
written consent.

Data
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Data were collected through face-to-face interviews using a questionnaire that
we developed from Mexican national and Latin American surveys [51, 53, 54], and
established TB risk assessments used by the UANL Hospital [55, 56]. Interview
questionnaires were identical for cases and controls. We partitioned these data into
individual (i.e., host) and social groupings that reflected broader environmental
characteristics that mediate the risk factors of the individual [1, 2]. Although certain
variables, like education, can be difficult to distinguish between individual and social
categories, the benefit of considering these two groupings was to recognize more
comprehensive measures of socioeconomic status apart from simplistic measures at an
individual-level [12, 57].
Individual variables included age, sex, self-reported indigenous ethnicity,
education, employment history, personal knowledge about TB transmission and cure,
alcohol and substance use, and BCG vaccination history (Appendix A, supplementary
table A.1). Health characteristics included first- and second-hand smoking exposure,
chronic conditions, and protein intake. Genetic ancestry was estimated from 291,917
single nucleotide polymorphisms (SNPs) assayed on DNA extracted from mouthwash
samples (Illumina HumanCyotoSNP-12 v2.1 DNA Analysis BeadChip Kit). The same SNPs
from 45 Native American, 54 European, and 40 African samples from the CEPH-Human
Genome Diversity Panel were used for ancestral population references [58]. The chip
contains a subset of 2.2 million SNPs common in Yoruban, Utah Mormon, Chinese and
Japanese individuals in the International HapMap Project. We reviewed medical records
to confirm demographic information and disease diagnoses, such as diabetes and
history of alcohol problems.
Social variables comprised a wide-range of residential and socioeconomic
factors. We ascertained data on marital status, housing structural conditions, TB
contact history, and household characteristics of wealth (Appendix A, Supplementary
table A.2). Socioeconomic status was estimated using a 10-question survey developed
by the Mexican Association of Marketing Research and Public Opinion Agencies (AMAI)
[53]. The 10 items measured computer and colored television ownership, type of floor,
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number of rooms, functioning shower, exclusive bathroom, number of lights, type of
stove, number of automobiles, and human capital measured by the educational
achievement of the person earning the highest income in the household [59]. These
variables differed from the individual-focused socioeconomic variables because they
captured characteristics at a household-level. According to the AMAI protocol, points
were assigned for each response for a total score ranging from zero to 366 points, and
then categorized into six socioeconomic categories based on total point scores. We
collapsed the six groupings into three categories representing upper-middle through
highest, middle, and low-middle through lowest, due to insufficient cell counts but that
still reflected the socioeconomic variation in the sample. The purpose of these
categorizations allows for cross-regional comparisons of socioeconomic status
throughout Mexico [60]. Each item on the 10-item AMAI survey was measured
individually to assess its association with TB status, as well as the total composite
survey.
Several additional social variables that estimated residential features included
access to the hospital as measured by travel time to the UANL hospital in minutes,
urban versus rural childhood residence, transportation by public or private vehicle,
presence of a factory in the neighborhood, and municipality of residence. We also
queried participants about their history of incarceration, residence in homeless
shelters, and residence in nursing homes (Appendix A, Supplementary table A.2).

Statistical analysis
The SNPs were analyzed using Plink 1.05 [61] and R 2.14.2 [62]. Individual Native
American, European, and African genetic ancestry proportions were estimated using
maximum likelihood [63, 64]. The ancestry estimates presented are from a random
subset of 10% of the loci, after filtering for minor allele frequencies of less than 5% and
missing genotypes of greater than 5%, for an analyzed subset of 24,642 SNPs.
We assessed crude associations of individual and social characteristics with TB
status (latent infection vs. active disease) using odds ratios (OR) with 95% confidence
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intervals (CI), as well as Pearson’s chi-square and Fisher’s exact tests [65]. Multivariable
logistic regression models were constructed from the variables in crude analyses that
showed an association with active TB at a p-value of 0.10 or less. Variables in the logistic
regression models were assessed for multicollinearity using a variance inflation factor
cutoff of 2.5 [66]. The final regression model was selected based on the minimum
Akaike Information Criteria (AIC), which represented the best fitted model [67].
Statistical analyses were conducted in SAS 9.2 (SAS Institute Inc., Cary, NC 2008).

RESULTS
Table 2.1 summarizes the demographic and socioeconomic characteristics of the
sample. The mean age of participants was 43.8 years (± 15.9) and the majority of the
sample was male (56.9%), self-reported non-indigenous ethnicity (79.6%), nonprofessional or never employed (67.9%), middle-level socioeconomic status (53.3%),
and with a secondary educational level or less (66.4%). The average Native American,
European, and African genetic ancestry proportions for the sample were 55.0% (range
25.2 – 92.6%), 37.9% (range 6.2 – 66.8%), and 7.2% (range 0.9 – 13.3%), respectively.
Half of the sample lived in the municipalities of Monterrey and Guadalupe, although all
nine municipalities of the MMA were represented.
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Table 2.1. Demographic and socioeconomic summary of sample (N=137)
Demographic and Socioeconomic
Characteristics
Mean ± s.d.
43.8 ± 15.9
37.9 ± 11.3
55.0 ± 12.5
7.2 ± 2.3
N (%)

Age in years
European genetic ancestry proportion
Native American genetic ancestry proportion
African genetic ancestry proportion
Sex
Female
Male
Indigenous ethnicity
Indigenous heritage and/or language
Non-indigenous
Principal lifetime employment
Professional, semi-professional, student
Non-professional or never employed
Current socioeconomic status
Highest, Upper-Middle
Middle
Lowest, Low-Middle
Educational attainment
Less than primary through secondary
Commercial, technical, college, specialist
Residence in Monterrey Metro Area (MMA)
Monterrey
Guadalupe
Santa Catarina
Apodaca
San Pedro Garza García
San Nicolás de los Garza
Juárez
General Escobedo
García
Outside the MMA

59 (43.1)
78 (56.9)
28 (20.4)
109 (79.6)
44 (32.1)
93 (67.9)
39 (28.5)
73 (53.3)
25 (18.3)
91 (66.4)
46 (33.6)
50 (36.5)
18 (13.1)
5 (3.7)
15 (11.0)
3 (2.2)
11 (8.0)
4 (2.9)
10 (7.3)
4 (2.9)
17 (12.4)
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In the crude analysis, 10 variables were associated with active TB (p ≤ 0.10)
(Table 2.2). Significant individual-level variables included having a secondary education
or less, non-professional or unemployed history, diabetes, a history of alcohol abuse,
and a lack of knowledge of TB transmission. Social conditions associated with active TB
included marital status, a secondary education or less among the highest income earner
in the home, and history of incarceration. While the AMAI-based composite measure of
household socioeconomic status was not associated with TB status, two components
showed significant associations- a lack of a functioning shower, no computers in the
household. (Supplementary tables in Appendix A show all individual and social variables
with their crude associations with active TB status.)
Table 2.2. Crude and adjusted logistic regression analysis (N=137)
Variable

Individual characteristics
Educational attainment
Less than primary through
secondary
Commercial, high school, or
higher
Principal lifetime employment
Professional, semiprofessional, student
Non-professional or
unemployed
Diabetes
No
Yes
History of alcohol problems
No
Yes
Knowledge of TB airborne
transmission
No
Yes
Social characteristics
Marital status
Single, divorced, separated,
widow
Married, free union
Presence of functioning
shower in the house

Cases
n = 97
N (%)

Controls
n = 40
N (%)

Crude
Odds Ratio
(95% CI)

Crude
pvalue

70 (72.2)

20 (50.0)

2.35 (1.1, 5.0)

0.03

27 (27.8)

20 (50.0)

Reference

--

26 (26.8)

18 (45.0)

Reference

--

71 (73.0)

22 (55.0)

2.24 (1.04, 4.82)

0.04

69 (71.1)
28 (28.9)

34 (85.0)
6 (15.0)

Reference
2.42 (0.92, 6.38)

-0.07

84 (86.6)
13 (13.4)

39 (97.5)
1 (2.5)

Reference
6.04 (0.76, 47.79)

-0.06

21 (21.7)
76 (78.4)

3 (7.5)
37 (92.5)

3.41 (0.96, 12.16)
Reference

0.06
--

50 (51.6)

12 (30.0)

2.48 (1.13, 5.44)

47 (48.5)

28 (70.0)

Reference
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Adjusted*
Odds Ratio
(95% CI)

Adjusted
p-value*

Reference
2.48 (1.0, 6.8)

-0.08

0.02

2.89 (1.3, 6.6)

0.01

--

Reference

--

No
Yes
Number of personal
computers
0
1 or more
Educational attainment of
highest income earner in
household
Less than primary through
secondary
Commercial, high school, or
higher
Ever been a resident in prison
No
Yes

11 (11.5)
85 (88.5)

1 (2.5)
39 (97.5)

5.05 (0.63, 40.48)
Reference

0.09
--

59 (62.1)
36 (37.9)

17 (42.5)
23 (57.5)

2.22 (1.05, 4.70)
Reference

0.04
--

65 (68.9)

20 (50.0)

2.32 (1.1, 5.0)

0.03

28 (30.1)

20 (50.0)

Reference

--

86 (88.7)
11 (11.3)

39 (97.5)
1 (2.5)

Reference
5.00 (0.62, 40.00)

-0.10

2.28 (1.0, 5.1)
Reference

0.04
--

*Odds ratios are adjusted for all variables in the table

These 10 variables were analyzed using multivariable logistic regression. The
results of the best-fitted final regression model based on the minimum AIC are shown
in Table 2.2. Diabetes was the only individual-level variable retained in the final model;
individuals with active TB disease had two and half greater odds of having diabetes
compared to individuals with latent TB infection (OR 2.48, 95% CI 1.0, 6.8). Of the social
characteristics, marital status and computers in the home were independent predictors
of TB disease. Cases were almost three times more likely to be single, divorced,
separated, or widowed than controls (OR 2.89, 95% CI 1.3, 6.6). Cases were over two
times more likely to not own a computer than controls (OR 2.28, 95% CI 1.0, 5.1).

DISCUSSION
TB presents an interesting disease phenotype because only 10% of infected
individuals ever progress to active disease status [9], and non-European groups are
disproportionately affected [10, 41]. Known risk factors for TB disease tend to focus on
host factors, with increasing recognition of the underlying role of social structures that
mediate risk [4]. Social conditions vary across populations and may help explain group
differences in TB disease rates, but the MMA in Nuevo León presents a paradox since it
has disproportionately high TB mortality and morbidity rates [22], despite being one of
the wealthiest and most developed urban centers in Mexico [42]. Variation in genetic
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ancestry has also been used as an explanation for TB discrepancies across populations
[47, 68] with the assumption that ancestry is informative of group-level differences in
TB-risk alleles, although this has never been formally tested using genetic markers. As a
first step towards addressing these problems, we tested the hypothesis that genetic
ancestry independently contributed to TB disease, while considering a wide variety
individual and social characteristics. Active TB cases and latent TB controls were
recruited from comparable populations, and by recruiting controls with confirmed
latent TB infection, we were able to explore predictors of active disease among at-risk
individuals. Overall, we found that genetic ancestry did not independently contribute to
TB disease. Instead, diabetes, marital status, and computer ownership were the main
correlates in this clinic-based sample in the MMA.
Diabetes is an important host risk factor for active TB due to impairment of
immune defenses [69-71]. Our results are similar to a recent meta-analysis that
reported a three-fold risk for active TB among diabetic patients compared to nondiabetic individuals [72]. A recent study conducted in southern Mexico concluded that
diabetes may be on par with HIV co-infection in terms of co-morbidity with TB in
Mexico, especially given the increasing incidence of diabetes throughout the country
[73]. The prevalence of diabetes among TB patients along the border of Texas and
northeastern Mexico is among the highest in the world [74], and further
characterization of social and demographic factors of this co-morbid population in this
region is needed. Diabetes is an important contributor to new TB cases, and it is
suggested that this relationship is bidirectional since active TB may predispose people
to diabetes through impaired glucose tolerance [71], although evidence of this
association is inconclusive [75]. A greater emphasis on proper diabetes management
and prevention may benefit TB control efforts [72, 74], especially in developing
countries where TB is endemic and rates of diabetes are rapidly increasing [71].
Being married or in a lifetime partnership is increasingly recognized as a
protective factor against active TB, independent of socioeconomic status [76-78].
Marital status is shown to mitigate TB disease severity and mortality [79], possibly
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reflecting the influence of spousal influence on latent TB treatment completion [80].
Our finding of a significant association between active TB and being unmarried is
suggestive that being married may play a protective role against progressing from latent
infection to disease status. Corroborating evidence suggests the beneficial impact of
“cohesive marriages” on physical and mental health [81]. Conversely, it is possible that
individuals with chronic illnesses like TB may be less likely to be in a lifetime partnership
due to the strain that the disease creates in the relationship [81, 82].
One unique finding of this study is the association between active TB and not
having a computer in the household. A recent multilevel study in Recife, Brazil, found
that living in an area where few households owned a computer was an important arealevel predictor of risk of developing TB [83]. Presence of a computer likely serves as a
unique proxy for socioeconomic status in the MMA, since none of our more direct
measures of education, employment, and income were predictive of TB status in our
final regression model. In fact, computer ownership in our sample was significantly
associated with other socioeconomic variables (Appendix A, Supplementary table A.3).
The measure of computers in the home might be more informative than a simpler
measure of education or literacy, especially given that some studies have failed to show
an association between years of schooling and TB disease [84] and latent infection
treatment completion [80]. This finding may reflect the importance for access to healthrelated information or possibly it indicates access to resources. Internet access afforded
by personal computers can directly affect health literacy [83], health-seeking behaviors,
and treatment adherence [57]. The finding that not having a computer in the home is
independently associated with active TB suggests a new way to identify high-risk areas
in the MMA for more targeted public health interventions.
More direct measures of socioeconomic status, such as the 10-item survey
(AMAI), and household crowding and income, were not predictive of TB disease status.
This result could reflect the fact that we took great pains to ensure that our controls
were representative of cases in terms of certain socioeconomic measures. Another
possibility is that the 10-item survey used to measure socioeconomic status included
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questions that were not relevant for this industrialized center, such as the use of
biomass cook stoves. Variation in the impact of risk factors between and within regions
emphasizes the need for more region- and community-specific studies of the
determinants of health and health disparity, as well as the development of area-specific
health policies.
In our sample, genetic ancestry was not associated with TB disease. This was
inconsistent with the hypothesis that European genetic ancestry is protective against TB
due to natural selection that conferred resistance to TB in peoples of Western
European descent [46, 47, 85-87]. However, linkage between genetic ancestry and
health related phenotypes is a function of the dynamics of the admixture process and
organization of genetic variation in this region, which has never been assessed strictly in
individuals with latent and active TB phenotypes. We plan to use the detailed genetic
data collected for this study to explore the admixture process and its health-related
implications.
Clear discrepancies in TB rates worldwide support the notion that people of
predominately African and Native American ancestry are disproportionately susceptible
to TB, whether due to underlying genetic variation and/or social disparities. In our
sample in the MMA, group variation based on ethnicity and/or genetic ancestry may
not be relevant for TB disease, especially since self-reported indigenous ethnicity was
not associated with active TB, nor was genetic variation based on European, Native
American, or African genetic ancestry. Although genetics undoubtedly play an
important role in TB susceptibility [87-92], genetic ancestry may not be a useful proxy
to capture the genetic basis of risk.
Several limitations of this study are important to note. First, the relatively small
sample size may affect power and explain the lack of significance in certain variables
that tend to be significant in other studies. The wide confidence intervals and
borderline significance with several variables reflects the exploratory nature of this
study and the use of proxy measures of complex social and environmental variables,
and future studies should further explore these factors with larger samples. The
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generalizability of study findings may be limited to industrialized, urban areas in
developing countries. Lastly, social structures that predispose individuals to TB disease,
such as political, economic, and cultural conditions, can be difficult to examine
thoroughly, and our attempt to address some of these factors did not capture its
entirety. For example, future work would benefit from including community-level
measures of income inequality [93] and health service disparities [4] to dig deeper into
social determinants of TB disease.
This study has several notable strengths. No previous study, to our knowledge,
has incorporated such a large number of SNPs, including markers of ancestral
populations, to formally assess the association of genetic ancestry and active TB. This
integration of genetic ancestry, self-reported ethnicity, and social data is important for
understanding the range of proximal and distal factors associated with TB disease [94].
Another strength of this study was our stringent criteria for control enrollment by a
positive PPD test [95, 96]. Many case-control studies assume controls have latent TB
infection if they live in a TB endemic area, but without testing for immune reactivity,
there is the potential for enrolling people that have not been exposed or infected, and
therefore do not actually represent an at-risk group for developing active disease.
Confirmation of medical conditions and TB history through medical record reviews
ensured accurate data on TB-related co-morbidities. Finally, the comparable source
populations for cases and controls from representative populations based on already
well-known TB risk factors allowed for further exploration of lesser-known variables,
such as material possessions that were indicative of socioeconomic status specific to
the MMA (i.e., computer ownership) [95].

Conclusion
This exploratory study assessed the role of genetic ancestry’s contribution to TB
disease susceptibility and identified potentially significant individual and social
predictors of active TB among a clinic-based sample in the MMA. Genetic ancestry was
not informative of TB status, while diabetes, marital status, and computer ownership

20

were independent predictors. The causes of TB disease disparities will be better
understood by assessing population-specific social conditions that mediate individual
risk. This study highlights the importance of addressing broader social conditions in TB
prevention efforts.
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CHAPTER 3: REJECTION OF A “ONE-TIME” ADMIXTURE HISTORY AND IMPLICATIONS
FOR GENETIC STUDIES OF INFECTIOUS DISEASE

INTRODUCTION
Genetic admixture occurs when two or more previously isolated “parental”
populations intermix [97, 98]. Allele frequency differences that accrue in the parental
populations during isolation can be used to estimate their proportionate contributions
to individuals in the admixed population. If the parental populations also differ in the
frequencies of disease-causing alleles, the admixture process can create non-random
associations, or linkage disequilibrium, between the disease-causing alleles and the
alleles used to estimate ancestry [99]. These associations will gradually decay over time
as a function of the recombination rate between the markers and the number of
generations since the admixture event, unless they are maintained by continuous gene
flow from one or more of the parental populations or assortative (i.e., nonrandom)
mating in the admixed population [100, 101].
Genetic ancestry is increasingly used in biomedical studies of admixed
populations to learn about disparities in multifactorial disease in the parental
populations [97, 102, 103]. These studies assess whether genetic ancestry is predictive
of disease status, independent of confounding social variables. Reiner and colleagues
found, for example, that African genetic ancestry proportions predicted blood glucose
levels among African Americans independent of environmental factors [104]. Other
studies have identified independent associations between genetic ancestry and disease
risk for breast cancer and type 2 diabetes among Hispanic American women [105, 106],
and type 2 diabetes in African American women [106]. The results of these studies
suggest that health disparities are partially due to differences in underlying risk alleles
in the parental populations that contributed to the admixed group.
While most admixture-disease studies focus on chronic diseases, the approach is
applicable to infectious diseases, like tuberculosis (TB) [9]. Pulmonary TB disease rates
show clear discrepancies across populations [6], with consistently lower rates in
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individuals with predominately European ancestry [6, 10]. Differential exposure to
adverse social, economic, political, and cultural conditions contributes in large part to
these discrepancies [1, 3, 4, 11, 37], but differences in genetic variation that affect
immune response to the causative pathogen, Mycobacterium tuberculosis [14, 15, 107,
108] may also play an important role [16, 109-111].
A recent case-control study of TB in Monterrey, Mexico (Young et al.,
unpublished) did not find an association between genetic ancestry and TB disease after
controlling for key sociocultural factors. They hypothesized that any association that
might have existed following initial admixture between Native American, European and
African individuals was gradually eliminated in the randomly mating hybrid population
[28, 112]. Under this “one-time” admixture scenario, even if differences in TB-causing
alleles existed in the parental populations, and even if these alleles contribute to TB
disease variation in Monterrey, there would be no association between TB disease and
genetic ancestry today.
Figure 3.1 diagrams this one-time admixture process with contributions from
three parental populations in proportions p 1, p2 and p3 [98, 100]. Following this initial
admixture event, there is no additional contribution from the parental groups and
mating is random in the hybrid population. The dashed lines in the figure illustrate
alternative scenarios involving continuous contributions from the parental populations
[100].
Figure 3.2 shows a simple version of this one-time admixture process in which
only Native American and European parental populations contributed in equal
proportions to the admixed population 15 generations before the present (p 1,0 = p2,0 =
0.50, p3,0 = 0) [98, 100]. The plots in the center of the figure show the probability for a
random individual in the admixed population to have a given fraction of ancestry from
the Native American parent after 1, 5, 10 and 15 generations. Without continuous gene
flow from any of the parental populations, the distribution remains symmetric around
0.5, the initial proportionate contribution from the Native American population [100].
Due to recombination and independent assortment, the variation in this probability
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decreases gradually over time, e.g., after 15 generations, the expected variance in
Native American ancestry is 7.6 E-06 [100]. In this situation, individual ancestry
estimates will show minimal variation after 15 generations of random mating, and
therefore will not have the potential to show associations with disease phenotypes. The
probability distribution takes different forms in the case of continuous contributions
from one or more parental populations or assortative mating, but, importantly, in these
cases, variation in ancestry proportions, and associations between genetic markers of
disease and ancestry can persist indefinitely.

Figure 3.1. Diagram of a “one-time” admixture process (solid blue lines) with
proportionate contributions from three parental populations, p 1, p2 and p3 at
generation 1. The dashed gray lines indicate alternative scenarios in which the parental
populations continue to contribute to the admixed populations. Adapted from Verdu
and Rosenberg 2011, supporting material Figure S1 [100].
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Figure 3.2. Simple version of the one-time admixture process for the case of p1,0 = p2,0 =
0.5, p3,0 = 0. The plots in the middle show the probability for a random individual in the
admixed population to have a given fraction of ancestry from the Native American
parent after 1, 5, 10 and 15 generations. Adapted from Verdu and Rosenberg 2011,
Figure 2 [100].

Our goal in this study is to test the one-time admixture scenario by comparing
the observed variation in genetic ancestry in the MMA today to that predicted after 15
generations, roughly equivalent to 500 years, since European and African populations
first came to the Americas. If we fail to reject this scenario, then genetic ancestry
cannot predict TB-disease status independent of social factors that might be associated
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with genetic ancestry. If we do reject it, the finding of no association between genetic
ancestry and active pulmonary TB in Monterrey suggests: 1) genetic components of TB
disease risk do not vary in the parental groups that formed the MMA; 2) effects of
genetic factors that differ in the parental populations are low compared to social
factors; or 3) power was too low to detect existing associations. We consider the
broader implications of our results for using genetic ancestry to investigate genetic
contributions to disparities in multifactorial diseases in the Americas.

MATERIALS AND METHODS
Study population and sample
Monterrey is the capital of Nuevo León in northeastern Mexico. The Monterrey
Metropolitan Area (MMA) is comprised of nine municipalities and is the third largest
metropolitan area in Mexico, totaling over 3.5 million inhabitants [33]. Approximately
90% of Nuevo León’s residents were concentrated in the MMA in 2009 [34]. Despite the
fact that the MMA is one of the wealthier and more developed population centers in
Mexico [42], it suffers from comparatively high rates of TB disease than other parts of
Mexico [22].
The data were collected as part of a study on the effects of genetic ancestry and
sociocultural variables on active TB status in the MMA. All participants signed an
informed consent document, and the project was approved by the Institutional Review
Boards at the University of New Mexico (UNM) and the Universidad Autónoma de
Nuevo León (UANL).
Study participants included adults with confirmed active pulmonary TB (n=83)
and latent TB infection (LTBI) (n=59) recruited from the UANL “Jose E. Gonzalez”
Hospital in Monterrey. Participants with active TB were present at the hospital for
diagnosis, treatment, or follow-up, and participants with LTBI included people in waiting
rooms, hospital personnel, and patients present for other conditions. The hospital’s
policy of treating patients independent of insurance status or ability to pay makes it a
catchment site for residents from all nine municipalities of the MMA.
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We conducted face-to-face interviews to collect detailed demographic and
socioeconomic data. Interview questions were developed in conjunction with local
researchers and included questions from Mexican and other Latin American-based
surveys [53, 54] and TB-risk assessments used at the UANL Hospital [55, 56].
Demographic variables included age, sex, and birth location. Measures of
socioeconomic status included education, employment history, household income, and
the Mexican AMAI 10-item survey that measured material wealth, housing conditions,
and human capital [53]. The AMAI survey is scored by each question and points range
from zero (lowest socioeconomic status) up to 366 (highest socioeconomic status).
Indigenous ethnicity was assessed by self-report and indigenous language spoken
personally or by a family member. Hospital medical records were reviewed to confirm
demographic information and TB status.

Genetic data
DNA was extracted from mouthwash rinses in the molecular anthropology
laboratory at UNM using a modified Puregene extraction protocol. Extracts were
genotyped at the University of Michigan’s DNA Sequencing Core. The genotypes
consisted of 291,917 single nucleotide polymorphisms (SNPs) on the Illumina
HumanCyotoSNP-12 DNA Analysis BeadChip Kit [113]. The chip contains a subset of 2.2
million SNPs common in Yoruban, Utah Mormon, Chinese and Japanese individuals in
the International HapMap Project [114]. All SNP call rates exceeded 99%. To control for
potential genotyping errors, we filtered the SNPs for minor allele frequencies of < 5%
and missing genotypes of > 5%, resulting in a set of 246,420 SNPs for admixture
analysis. Plink was used for the management of genetic data [61].
A total of 281 individuals were included in the genetic analysis. The MMA
sample was comprised of 142 participants, and we additionally genotyped 54
Europeans, 45 Native Americans, and 40 Africans from the HGDP-CEPH Human Genome
Diversity Cell Line Panel to serve as proxies for the parental populations [58]. The
Europeans included French, Adygei, Orcadian, Russian, Sardinian, and Tuscan
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individuals. The Native Americans included Mexican Pima, Maya, Colombian, Karitiana,
and Surui individuals. The Africans were comprised of Yoruba, Mandenka, Bantu, and
San individuals. We ran two sets of admixture analyses. In one set, all regional samples
were used to represent European, Native American, and African parental populations.
In the second set, we used only the French, Pima, and Yoruban individuals as proxies for
the ancestral populations. Admixture estimates were essentially identical for both sets
of analyses. Results presented in this paper are from the set that used regional samples
as parents.

Statistical analysis
We estimated individual European, Native American, and African ancestry
proportions for MMA participants with the method of maximum likelihood [63].
Estimates were obtained from random subsets of 10% of the filtered loci (24,642 SNPs)
[63, 64]. We tested the one-time admixture process by comparing the observed
variance in ancestry proportions in our MMA sample to the predicted variance after 15
generations, given by V[H15] = px,0(1-px,0)/2g, for each of the three parental populations,
x. The null hypothesis we tested is that our observed variance of ancestry estimates
from the MMA sample are not significantly different from the expected variance of
ancestry estimates under a one-time admixture history. This was assessed by testing
the ratio of the observed variance/ dfobserved to the expected variance/ dfexpected equals
1.0. This ratio is an F-distributed random variable with dfobserved = dfexpected = 141
(degrees of freedom).
We used a likelihood ratio statistic, G = −2 [(ln L (μx) − ln L (ˆμi ))] to identify
individuals whose ancestry proportions deviated from expected under the one-time
model [100, 115]. In the equation, x is the average ancestry proportion from parental
population x, and i is the ancestry fraction that maximizes the likelihood function for
the ith individual. The null hypothesis is that μi = μx. G is distributed as a 2 random
variable with degrees of freedom equal to the number of parental populations minus
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one [116]. We used triangle plots of genetic ancestry to highlight the demographic
characteristics of individuals for whom we rejected the null hypothesis.

RESULTS
Sample characteristics
Table 3.1 summarizes participant demographic and socioeconomic
characteristics. Our sample was representative of the MMA with respect to sex and
immigration status; about half of the sample was male (54.9%), and approximately half
were born in the MMA. Our sample was not representative with respect to several
other characteristics. First, since the sample was collected to study the correlates of
active TB disease, it had a high proportion of people with active TB disease (58.5%). The
median age of our sample was high compared to the median age for Nuevo León (42 vs.
26 years) [34], and the proportion of indigenous language speakers was high compared
to the proportion in the MMA at large (5.6% vs. 0.8%) [117]. The sample also had
slightly higher socioeconomic status than the municipality of Monterrey [60], likely due
to the fact that the LTBI participants included hospital personnel with higher levels of
education, employment, and income. These differences suggest that TB patients are not
a random subset of the surrounding community with respect to age, ethnicity and SES.
Table 3.1. Demographic and socioeconomic summary of participants (N=142)

Participant Characteristics
Age in years
European genetic ancestry proportion*
Native American genetic ancestry proportion *
African genetic ancestry proportion *

Mean ± s.d.
41.9 ± 15.2
40.1 ± 12.8
52.8 ±13.8
7.1 ± 2.3
N (%)

TB status
Active TB disease
Latent TB infection
Sex
Female
Male

83 (58.5)
59 (41.5)
64 (45.1)
78 (54.9)
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Immigration to Monterrey
Origin in Monterrey
Origin outside of Monterrey
Self-reported indigenous ethnicity
Yes
No
Indigenous language spoken
Yes
No
Principal lifetime employment
Professional, semi-professional, student
Non-professional or never employed
Educational attainment
Less than primary, secondary
High school, technical, college, specialist
Socioeconomic level**
Highest (A/B)
High (C+)
Upper moderate (C)
Moderate (D+)
Low (D)
Lowest (E)

72 (50.7)
70 (49.3)
24 (16.9)
116 (81.7)
8 (5.6)
134 (94.4)
64 (45.1)
78 (54.9)
76 (53.5)
66 (46.5)
21 (14.8)
38 (26.8)
27 (19.0)
41 (28.9)
10 (7.0)
5 (3.5)

*Genetic ancestry: 24,642 random SNPs (random 10% from filtered 246,420).
**Based on the Mexican Association of Marketing Research and Public Opinion
Agencies 10-item standardized survey [53].
Variation in ancestry: rejection of a one-time admixture model
Figure 3.3 summarizes individual genetic ancestry estimates for each MMA
individual. Genetic ancestry varied substantially among study participants, with sample
averages for Native American, European, and African genetic ancestry of 52.8% (± 13.8
s.d.), 40.1% (± 12.8), and 7.1% (± 2.3), respectively. Standard errors for individual
ancestry estimates ranged from 0.004 – 0.01%. While these individual ancestry
estimates fall within previously reported ranges for the MMA [26, 27, 48, 49], these
studies relied on fewer markers and had higher standard errors in individual ancestry
estimates.

30

Figure 3.3. Genetic ancestry proportions in the MMA. The plot consists of 142 vertical
bars representing the European, Native American and African ancestry proportions for
each individual in the sample.

Figure 3.4 shows histograms of ancestry estimates for each of the three parental
groups. The red vertical line shows the approximate expected range of ancestry under
the hypothesis of one-time admixture if: 1) the parental populations initially
contributed their respective mean amounts of observed ancestry, and 2) individuals in
the admixed population mated randomly for 15 generations. The range of observed
values is clearly much larger than that expected under the one-time process (FEur =
2251, FNA = 2487, FAf = 258, p-values < 0.0000).
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Observed vs. Expected Variance of Ancestry Proportions in the MMA

Figure 3.4. Histograms of individual genetic ancestry estimates in the MMA. The red
vertical lines encompass the narrow range of variation in ancestry expected after 15
generations under the one-time admixture history.
The ancestry data are illustrated using triangle plots in Figure 3.5. The
population mean is colored red. From the likelihood ratio test, the 20 individuals (14%)
that were statistically indistinguishable from the population mean are colored black;
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the remaining 122 individuals (86%) that significantly differed from the population
mean are colored blue. Based on the F and the likelihood ratio tests, we reject the onetime admixture process.

Figure 3.5. Individual ancestry estimates of the MMA. Blue dots (86% of sample)
represent individuals that showed significant differences from the mean, and the black
dots (14% of sample) are those that were indistinguishable from the mean.
To explore the potential processes driving our rejection of the one-time
admixture process, we used the triangle plots to highlight key demographic
characteristics of the sample. Figure 3.6 shows the same data as Figure 3.5, but this
time individuals are color-coded by birthplace (i.e., immigration status). The plot shows
that about half of the individuals in our sample were born outside of the MMA, as were
the majority of individuals with high Native American ancestry. In fact, all individuals
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with greater than 70% Native American ancestry were born outside of the MMA. Of
these 14 immigrants with greater than 70% Native American ancestry, 36% selfreported as indigenous and 43% spoke indigenous languages or had relatives that spoke
indigenous languages.

Figure 3.6. Ancestry estimates colored by immigration status to the MMA
In Figure 3.7, the individual ancestry data are color-coded to reflect recruitment
status of the TB study participants. The figure shows that hospital personnel, namely
nurses, secretaries, laboratory technicians, physicians, and medical students, had higher
than average European ancestry in our sample. These personnel also tended to have
higher socioeconomic status compared to the sample mean (238.5 AMAI points vs.
174.0 AMAI points). Approximately one-third of these individuals are also recent

34

immigrants to the MMA, but the majority is not. These patterns may reflect a
combination of employment-related immigration and assortative mating by ancestry
and socioeconomic status in the MMA.

Figure 3.7. Ancestry estimates colored by recruitment status of hospital personnel
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DISCUSSION
The variation in genetic ancestry in Mexico today reflects intermixing between
predominately Spanish men and Native American women starting around 1519 [28,
118], and Africans starting in the early 16th century [28, 118]. Some recent African
ancestry may also have entered through the European colonizers as a result of preColombian gene flow between North African and Iberian populations [28, 119]. The
Spanish and Portuguese continued to migrate to Mexico until the mid-19th century, and
the African slave trade ceased in 1850 [28, 118].
The earliest inhabitants of Monterrey, founded in 1596 [25, 118], would have
been comprised of the descendants of this intermixing. If the population in Monterrey
had mated randomly following initial admixture between these parental populations
beginning in the early 16th century, then we would expect the level of variation in
genetic ancestry the MMA to be much lower than the observed levels identified in this
study. Even if random mating only began in 1850 (approximately 7 generations), when
slave traffic ceased, the observed level of variation for the European and Native
American ancestry proportions would still greatly exceed the expected ( F Eur = 8.8, FNA =
9.7, p-values < 0.0000) [100]. However, the African component is in fact consistent with
the 7-generation onetime process (FAf = 1.0, p = 0.4816). This result is consistent with
prior evidence that Mexican spousal pairs do not exhibit assortative mating based on
African ancestry [120].
The demographic characteristics of our sample suggest that continuous
immigration of genetically distinctive peoples has played an important role in
maintaining variation in genetic ancestry in the MMA, particularly individuals with high
Native American genetic ancestry proportions. Immigration has played an important
role in the massive population growth in the MMA over the past 70 years [34]. In just
20 years between 1940 and 1960, 400,000 people immigrated to Nuevo León to seek
better living conditions and employment opportunities [121]. Many of these migrants
came from regions with higher proportions of indigenous groups, e.g., San Luis Potosi,
Tamaulipas, Mexico City, and Durango [121, 122]. In our sample, 10% of all immigrants
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or their family members spoke indigenous languages, including Nauhuatl, Huasteco,
Otomi, and Azteca. Six of the 14 individuals (43%) with greater than 70% Native
American ancestry spoke indigenous languages. This continuous immigration of Native
American peoples accounts for a large portion of the variation in genetic ancestry in our
sample.
Assortative mating by ancestry or socioeconomic status may also explain
deviations from the predictions of the one-time process. Many of the individuals with
high European ancestry in our sample were relatively high socioeconomic status
hospital staff. European ancestry is correlated with socioeconomic status in other large
urban centers in Mexico (116). A previous study of spousal choice in Mexico City and
the San Francisco Bay Area also showed strong correlations for assortative mating by
European ancestry as well as by Native American ancestry [120]. These ancestry-based
correlations for spousal pairs persisted even within socioeconomic categories and
geographic subgroups [123, 124]. These results suggest that assortative mating has also
played an important role in maintaining high levels of variation in genetic ancestry in
the MMA.
Given its wide range of variation in the MMA, genetic ancestry has the potential
to be informative about genetic differences in TB risk between the parental
populations. However, in our recent study of the correlates of active pulmonary TB in
the MMA, we found no association between TB-disease status and genetic ancestry
(Young et al., unpublished). These findings suggests that: 1) genetic differences in TBcausing alleles do not exist between the ancestral populations that formed the
Monterrey population, 2) any genetic differences that do exist contribute
proportionately little to variation in TB disease compared to sociocultural factors, or 3)
power was too low to detect existing associations.
With respect to the possibility that genetic differences in TB-causing alleles do
not exist between ancestral populations that formed the MMA, there is weak evidence
that genetic variation underlying susceptibility is geographically structured. The
SLC11A1 gene, which is crucial in host immunity against infections, presents a good
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example of this inconsistency. Two recent meta-analyses looked at the effects on TB
susceptibility across populations from polymorphisms of the SLC11A1 gene. Li and
colleagues identified differences in odds ratios between groups and differences in allele
frequencies, and concluded that these allele frequency discrepancies might account for
the variation in genetic risk across populations [90]. However, a more recent metaanalysis in 2011 compiled data from a larger number of studies and reported no
differences in odds ratios between populations based on SLC11A1 variation [16].
Although both studies show contributions of SLC11A1 variation on TB susceptibility,
there is no support for a group-specific effect of SLC11A1 polymorphisms and TB
outcomes.
Genetic differences related to TB disease susceptibility that do exist often have
relatively low effect sizes. Again, with SLCA11A1 polymorphisms, summed odds ratios
for the 3’ UTR variant was 1.35 (95% CI 1.17, 1.54), the D543N variant was 1.25 (95% CI
1.04, 1.50), the INT4 variant was 1.23 (95% CI 1.05, 1.44), and the 5’ GT variant was 1.31
(95% CI 1.08, 1.59) [16]. Similarly low effect sizes and insignificant results are reported
in meta-analyses for other TB-related genetic polymorphisms, such as with SP110 [110],
P2X7 [125], TIRAP S180L [126], and the vitamin D receptor [109].
In contrast, numerous publications have demonstrated the role played by social
factors in mediating TB disparities, most notably those associated with poverty and
socioeconomic inequalities [1, 2, 4, 11, 37, 127]. For example, an analysis of 22
countries that bear 80% of the global TB burden concluded that HIV, malnutrition,
smoking, diabetes, alcohol abuse, and indoor air pollution contributed substantially to
population-level risk [128]. A systematic review of alcohol consumption concluded that
approximately 10% of global TB cases were attributable to alcohol abuse [129]. Recent
multilevel analyses in Brazil and South Africa highlighted the important effects of
community-level factors on TB risk [83]. In the Brazil study, extreme poverty had a
strong effect (OR 4.3, 95% CI: 2.9-6.3), and the authors concluded that 65% of all TB
cases were explained by socioeconomic variables [83]. Income inequality was
highlighted in the South Africa study as an independent risk factor for TB disease (OR
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2.4, 95% CI: 1.6-3.5) [93]. Overall, the consistency of the findings in these studies, and
the magnitude of the effects they report, suggest that variation in sociocultural factors
is likely to play a more important role in TB risk than variation in genetic factors [130132].

Conclusion
This study highlights the need for biomedical researchers to assess whether
genetic ancestry in admixed groups has the potential to capture genetic differences in
disease risk between the parental populations. Under a one-time admixture model,
associations between genetic ancestry and disease-causing alleles, and variation in
genetic ancestry in general, will quickly disappear. In admixed populations that
experienced a one-time admixture event in the distant past, any current association
between genetic ancestry and disease phenotypes must reflect unaccounted for
sociocultural factors, not genetic differences in disease risk between the parental
populations. Under more complex admixture histories, ancestry-disease marker
associations may be maintained in the hybrid population, but only if disease-causing
alleles show distinct differences across parental populations, and only if samples sizes
of the admixed population have the power to detect effect sizes that are likely, in many
cases, to be quite small. In either case, in countries throughout the Americas where
healthcare resources are limited, prevention efforts may be better spent on addressing
the known social conditions that so strongly affect multifactorial disease burden.
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CHAPTER 4: CRACK COCAINE USE AND DRUG-RESISTANT TB

INTRODUCTION
Drug-resistant tuberculosis (DRTB) is a major public health problem worldwide
that complicates TB prevention and care services in three important ways [6]. First,
treatment for drug-resistant cases is 50 to 200 times more expensive than for drugsusceptible cases, and treatment duration is at least three times longer (18-24 vs. 6
months) [133]. Second, DRTB requires increased supervision from healthcare providers
because more medications are required to treat the disease and because these
medications are less potent and produce more serious side effects. Third and most
importantly, the cure rate for drug-resistant cases averages only 70%, compared to 9095% for drug-susceptible cases [6, 134]. In Mexico, a steady increase in DRTB was seen
among new cases from 2000 to 2010 [22]. Nuevo León, a state in northeastern Mexico
that shares a border with Texas, was tied with Baja California for being the second
highest for drug-resistant cases in 2010 [22].
The predominate risk factors associated with selection for drug resistance have
been categorized into community factors and patient conditions that increase
vulnerability [17]. Community factors largely involve substandard healthcare services
that influence risk [4]. Examples include high costs of treatment, inadequate healthcare
access, improper dosing or duration of drugs, unavailable or poor quality drugs, and
lack of directly observed treatment [4, 17, 135, 136]. Patient factors typically focus on
predictors of loss to follow-up (i.e., treatment default), and therefore are indirect
measures of risk for DRTB. These often include behavioral and social factors, such as
illicit drug use, alcohol abuse, homelessness, incarceration, low education and income,
impoverished housing conditions, and unfavorable patient-provider relations [137-141].
Patient factors that have been directly correlated with DRTB, such as age, sex, and HIV,
are inconsistent across studies [133, 135]. In light of increasing rates of DRTB in Mexico,
it is important to identify risk factors associated with the selection of drug resistance
[142], particularly patient conditions that increase vulnerability for resistance [17].
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The urban center and capital of Nuevo León, Monterrey, offers a unique setting
to assess the correlates of DRTB because of routine drug-susceptibility testing (DST) at
the Jose E. Gonzalez University Hospital, and evidence of extensive DRTB and recent
transmission [31]. Throughout Mexico, most clinics and hospitals lack the resources for
routine DST among previously treated and new TB cases. Given the lack of resources
available for routine DST, a population-specific risk profile would benefit TB healthcare
providers to identify patient predictors of drug resistance at clinic visits [17, 19, 136,
141]. The goal of this study was to explore links between DRTB and a variety of patient
risk factors.

MATERIALS AND METHODS
Design and recruitment
This study is part of a larger project conducted between January 2010 and
February 2011 as a case-control study in the TB clinic at the Jose E. Gonzalez University
Hospital. The hospital is located in Monterrey, Nuevo León, which is a moderate to low
socioeconomic status municipality in the MMA [29, 30]. Residents from all nine of the
MMA municipalities come to this public hospital because of its policy to treat patients
regardless of insurance status or ability to pay.
The data presented here represent an exploratory secondary analysis from the
original study (Young et al., unpublished). Using the data from the original study, the
present analysis investigates patient risk factors of DRTB among pulmonary TB patients
attending the Jose E. Gonzalez Hospital. Active pulmonary TB participants (n = 95) aged
18 years or older were recruited from the hospital’s TB clinic who currently had active
disease or had ever been diagnosed with laboratory confirmation of active disease. All
participants had disease confirmation through a positive culture, and received standard
mycobacteriology DST to determine if they had drug-susceptible or DRTB [51]. We
defined drug resistance according to the World Health Organization’s (WHO) guidelines
as a TB isolate that is not susceptible to the action of one or more anti-TB drugs [51].
Cases consisted of 25 patients with resistance to at least one TB medication, and
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controls consisted of 70 patients who were sensitive to the four first-line medications.
Patients with diagnosed HIV and extra-pulmonary TB were excluded from the study.
This project was approved by the University of New Mexico and Autonomous University
of Nuevo León Institutional Review Boards, and study participants gave informed,
written consent prior to enrollment.

Data collection
To investigate patient risk factors for drug resistance, we conducted personal
interviews, reviewed medical records, and assayed genetic ancestry from DNA
polymorphisms. The interviews were based on questionnaires from Mexican and other
Latin American surveys and hospital risk assessments [53, 54]. They assessed a wide
range of patient factors known to be associated with active TB and possibly DRTB, such
as socioeconomic status, demographic characteristics, health features, and social stigma
[2, 143].
Socioeconomic status was measured using a nationwide survey designed for
market research in Mexico that compiled 10 questions related to number of rooms in
the house, housing materials and structure, possession of a colored television,
computer, and automobile, type of stove used, and education of the highest income
earner [53]. Personal education, employment history, household income, and
additional housing measures were also collected to estimate socioeconomic status.
Demographic characteristics included age, sex, marital status, and indigenous ethnicity
based on self-report and indigenous language spoken. Health features included alcohol
and substance abuse histories, co-morbidities, previous BCG vaccination, TB contact
history, prior TB treatment, and use of alternative treatments for TB.
Additionally, in order to explore issues surrounding social stigma, discrimination,
and fear towards the disease, patients were also asked during the interviews about
their knowledge and attitudes towards TB [143]. Social stigma was assessed by giving
the patient a hypothetical scenario of having a family member sick with TB, and then
asking if they would prefer to treat that family member in secrecy [54]. Patients were
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also asked if they had ever seen or felt discrimination related to TB in their community,
and if they had any fears related to TB, such as not being cured, spreading it to family,
or feeling isolated as a result of being sick [143].
Medical records were reviewed in the UANL Archival Department to confirm
diagnoses of co-morbidities, such as diabetes. TB-related data were also confirmed
through medical record reviews, including date of diagnosis and treatment history.
We measured genetic ancestry of participants because prior studies have
suggested that genetic ancestry is predictive of TB susceptibility and resistance [45, 46,
85]. DNA was extracted from mouthwash samples using a modified protocol of the
Puregene DNA Isolation Kit (QIAGEN, Inc., U.S. 2011). The extracts were genotyped for a
panel of 291,917 single-nucleotide polymorphisms (SNPs) that vary in frequency
between European, Native American, and West African parental populations (Illumina
HumanCyotoSNP-12 v2.1 DNA Analysis BeadChip Kit). These SNPs were also typed for
54 European, 45 Native American, and 40 African individuals from the Human Genome
Diversity Panel [58]. All SNPs were filtered by minor allele frequencies of less than 5%,
and missing genotypes of greater than 5%, resulting in a set of 246,240 markers.
Proportions of European, Native American, and African genetic ancestry were
estimated from random subsets of 10% of the filtered loci (24,642) using maximum
likelihood [64].

Data analysis
We tested the association of each variable with DRTB using Pearson’s chi-square
tests, and Fisher’s exact tests were calculated when cell counts were less than 5.
Potential risk factors that differed between drug-susceptible and drug-resistant cases at
an alpha level of 0.10 were introduced in the multivariable logistic regression models,
and the final model was selected based on a backward elimination procedure. Variables
in the logistic regression model were assessed for multicollinearity using a variance
inflation factor cutoff of 2.5 [66]. Crude and adjusted odds ratios (OR) and 95%
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confidence intervals (CI) were reported for the full and final models. All statistical
analyses were performed in SAS 9.2 (SAS Institute Inc., Cary, NC 2008).

RESULTS
A summary of patient characteristics is provided in Table 4.1. Overall, the
majority of participants were male (53.7%), of low socioeconomic status (55.8%),
unemployed or non-professional lifetime employment (73.7%), possessed a secondary
education or less (71.6%), and self-reported non-indigenous ethnicity (82.1%). Genetic
ancestry estimated from the SNPs ranged from 6.1 – 56.5% European, 37.1 – 92.6%
Native American, and 0.9 – 11.6% African. Mean sample estimates were 37.2% (s.d.
10.8), 55.7% (s.d. 12.3), and 7.1% (s.d 2.3) for European, Native American, and African
proportions, respectively. Participants came from all nine municipalities in the MMA,
although Monterrey had the highest representation (38.9%).

44

Table 4.1. Summary of study sample characteristics (N = 95)

Sample characteristics
Mean ± s.d.
44.9 ± 17.1
37.2 ± 10.8
55.7 ± 12.3
7.1 ± 2.3
N (%)

Age in years
European genetic ancestry proportion
Native American genetic ancestry proportion
African genetic ancestry proportion
Resistance to at least one anti-TB drug
No
Yes
Sex
Female
Male
Self-reported indigenous ethnicity
Indigenous heritage and/or language
Non-indigenous
Principal lifetime employment
Professional, semi-professional, student
Non-professional or never employed
Current socioeconomic status
Highest, Upper-Middle
Middle
Lowest, Low-Middle
Educational attainment
Less than primary through secondary
Commercial, technical, college, specialist
Residence in Monterrey Metro Area (MMA)
Monterrey
Guadalupe
Santa Catarina
Apodaca
San Pedro Garza García
San Nicolás de los Garza
Juárez
General Escobedo
García
Outside the MMA

70 (73.7)
25 (26.3)
44 (46.3)
51 (53.7)
17 (17.9)
78 (82.1)
25 (26.3)
70 (73.7)
25 (26.3)
17 (17.9)
53 (55.8)
68 (71.6)
27 (28.4)
37 (38.9)
13 (13.7)
3 (3.2)
11 (11.6)
2 (2.1)
6 (6.3)
3 (3.2)
5 (5.3)
3 (3.2)
12 (12.6)
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In univariable analysis comparing patient characteristics between drugsusceptible and drug-resistant participants, seven variables were associated with drug
resistance (p<0.10) (Table 4.2). BCG vaccination status was excluded from multivariable
models due to insufficient data for approximation, resulting in six variables for
introduction in multivariable models.
Drug-resistant patients were more likely than drug-susceptible patients to be
younger, have a history of marijuana, crack cocaine, and inhalant use, report social
stigma, and received prior TB treatment. All other variables failed to show significant
differences between drug-susceptible and drug-resistant patients, and drug resistance
status with respect to genetic ancestry was not significant (Table 4.2).
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Table 4.2. Crude associations between drug-resistant TB and individual and social
characteristics (N=95)
Variable

Age in years
European genetic ancestry %*
Native American genetic ancestry %*
African genetic ancestry %*
Mean total pack years**
Travel time to UANL Hospital (minutes)

Sex
Female
Male
Self-reported indigenous ethnicity
Indigenous heritage
Non-indigenous
Educational attainment
Less than primary through secondary
Commerical, high school, or higher
Principal lifetime employment
Professional, semi-professional, student
Non-professional or unemployed
Diabetes
No
Yes
History of alcohol problems
No
Yes
Asthma
No
Yes
Hypertension
No
Yes
Marijuana use
No
Yes
Crack cocaine use
No
Yes
Methamphetamine use
No
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Drugsensitive
(n = 70)
Mean ± s.d.
48.9 ± 17.7
36.6 ± 10.5
56.3 ± 12.1
7.1 ± 2.2
7.2 ± 17.6
65.4 ± 68.6

Drug-resistant
(n = 25)

N (%)

N (%)

35 (50.0)
35 (50.0)

9 (36.0)
16 (64.0)

0.23

55 (78.6)
15 (21.4)

23 (92.0)
2 (8.0)

0.13

52 (74.3)
18 (25.7)

16 (64.0)
9 (36.0)

0.33

17 (24.3)
53 (75.7)

8 (32.0)
17 (68.0)

0.45

49 (70.0)
21 (30.0)

17 (68.0)
8 (32.0)

0.85

60 (85.7)
10 (14.3)

23 (92.0)
2 (8.0)

0.51

69 (98.6)
1 (1.4)

24 (96.0)
1 (4.0)

0.46

62 (88.6)
8 (11.4)

24 (96.0)
1 (4.0)

0.43

65 (92.9)
5 (7.1)

20 (80.0)
5 (20.0)

0.07

66 (94.3)
4 (5.7)

19 (76.0)
6 (24.0)

0.02

69 (98.6)

23 (92.0)

0.17

Mean ± s.d.
39.2 ± 13.9
40.3 ± 9.9
52.5 ± 10.9
7.3 ± 2.3
5.4 ± 10.2
61.2 ± 41.4

p-value

0.05
0.14
0.17
0.77
0.63
0.77

Yes
Injection drug use
No
Yes
Inhalant use
No
Yes
Previously treated for TB
No (<1 month of treatment, ‘new case’)
Yes (≥1 month of treatment, ‘previously
treated’)
Knowledge of TB airborne transmission
No
Yes
Knowledge that TB is curable***
No
Yes
Social stigma by preference to treat a family
member with TB in secrecy
No
Yes
Ever saw or felt discrimination against TB
No
Yes
Ever felt fear related to TB
No
Yes
BCG vaccination***
No
Yes
History of family TB
No
Yes
Close contact with a TB patient
No
Yes
Place first learned about TB
Health clinic, doctors, hospital
Other (family, public media, school, books)
Use of alternative remedies/therapies to
treat TB
No
Yes
Marital status
Single, divorced, separated, widow
Married, free union
Household income per 15 days (pesos)
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1 (1.4)

2 (8.0)

68 (97.1)
2 (2.9)

23 (92.0)
2 (8.0)

0.28

69 (98.6)
1 (1.4)

22 (88.0)
3 (12.0)

0.05

21 (30.0)
49 (70.0)

2 (8.0)
23 (92.0)

0.03

14 (20.0)
56 (80.0)

5 (20.0)
20 (80.0)

1.0

5 (7.3)
64 (92.8)

0
25 (100.0)

0.32

61 (87.1)
9 (12.9)

18 (72.0)
7 (28.0)

0.08

44 (65.7)
23 (34.3)

12 (48.0)
13 (52.0)

0.12

34 (48.6)
36 (51.4)

9 (36.0)
16 (64.0)

0.27

17 (24.3)
53 (75.7)

0
25 (100.0)

0.01

41 (58.6)
29 (41.4)

19 (76.0)
6 (24.0)

0.12

38 (54.3)
32 (45.7)

13 (52.0)
12 (48.0)

0.84

52 (77.1)
16 (22.9)

18 (72.0)
7 (28.0)

0.61

53 (94.6)
3 (5.4)

22 (91.7)
2 (8.3)

0.63

37 (52.9)
33 (47.1)

12 (48.0)
13 (52.0)

0.68

<2,000
22 (38.9)
8 (33.3)
0.99
2,001 – 5,999
33 (50.8)
12 (50.0)
6,000 or higher
10 (15.4)
4 (16.7)
Current socioeconomic status****
Highest, Upper-Middle
17 (24.3)
8 (32.0)
0.26
Middle
41 (58.6)
10 (40.0)
Lowest, Low-Middle
12 (17.1)
7 (28.0)
Running water inside home
No
8 (11.4)
4 (16.0)
0.55
Yes
62 (88.6)
21 (84.0)
Normal mode of transportation
Personal car
15 (21.4)
8 (32.0)
0.29
Other (public bus, metro, taxi, bike)
55 (78.6)
17 (68.0)
Residence in MMA municipalities (SES
groupings based on geospatial analysis)
San Pedro, San Nicolás (high)
7 (10.0)
1 (4.0)
0.59
Monterrey, Guadalupe, García, Santa
42 (60.0)
14 (56.0)
Catarina (medium, medium-low)
Apodaca, Escobedo, Juarez (very low)
12 (17.1)
7 (28.0)
Outside the MMA
9 (12.9)
3 (12.0)
Ever been a resident in prison
No
62 (88.6)
23 (92.0)
0.63
Yes
8 (11.4)
2 (8.0)
Ever been a resident of a homeless shelter***
No
68 (97.1)
25 (100.0)
1.0
Yes
2 (2.9)
0
*Individual genetic ancestry estimated from 291,917 single nucleotide polymorphisms (SNPs)
**Total pack years calculation: (#cigarettes per day * years of smoking)/20
***Insufficient data for approximation
***Calculated from the AMAI Mexican 10-item survey (2008)
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In multivariable logistic regression containing these six patient characteristics,
only crack cocaine use remained an independent risk factor for drug resistance. We
combined marijuana and inhalants into one category and re-ran the model, which
resulted in identical final results (Table 4.3). After adjusting for all potential risk factors,
age, previous TB treatment, social stigma, and marijuana/inhalant use fell out of the
final model and were no longer significant predictors of DRTB. To summarize our final
results among this clinic-based sample of TB patients in the MMA, the odds of using
crack cocaine were over 5 times greater for DRTB patients compared to drugsusceptible TB patients (OR 5.21, 95% CI: 1.33, 20.4, p = 0.02).

Table 4.3. Crude and adjusted logistic regression analysis to assess predictors of drugresistant TB (N = 95)
Variable

Age in years
Previous TB treatment
No
Yes
Social stigma
No
Yes
Marijuana and/or
inhalant use
No
Yes
Crack cocaine use
No
Yes

Drugsensitive
n = 70
N (%)
48.9 ± 17.7

Drug-resistant
n = 25
N (%)

Crude
Odds Ratio
(95% CI)

Crude
p-value

39.2 ± 13.9

0.97 (0.94, 1.00)

0.05

21 (30.0)
49 (70.0)

2 (8.0)
23 (92.0)

Reference
4.93 (1.06, 22.8)

-0.03

61 (87.1)
9 (12.9)

18 (72.0)
7 (28.0)

Reference
2.64 (0.86, 8.07)

-0.08

65 (92.9)
5 (7.1)

19 (76.0)
6 (24.0)

Reference
4.11 (1.13, 14.95)

-0.03

66 (94.3)
4 (5.7)

19 (76.0)
6 (24.0)

Reference
5.21 (1.33, 20.39)

-0.02

Adjusted*
Odds Ratio
(95% CI)

Adjuste
d
p-value*

Reference
5.21 (1.33, 20.4)

-0.02

*Odds ratios are adjusted for all variables in the table

Due to the fact that crack cocaine use is often embedded in co-existing adverse
behavioral and socioeconomic conditions, we assessed the associations of crack cocaine
use with other patient characteristics using Fisher’s exact tests (Appendix B,
Supplementary table B.1). We found a strong association between crack cocaine and
socioeconomic factors, such that a significantly higher proportion of crack cocaine users
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had lower educational attainment, non-professional and unemployed status, history of
alcohol problems, hepatitis, other drug use, and several poor housing characteristics,
compared to those who had never used crack cocaine.

DISCUSSION
Knowledge of patient-specific factors that predict DRTB is important in Mexico
where routine DST screening is not obtained for diagnostic purposes due to limited
healthcare resources. It is well-known that demographic, health, and socioeconomic
characteristics can be predictive of people at risk for TB disease, but these broad
characteristics are not consistently associated with DRTB [133, 144]. As a result,
patients with increased risk for DRTB can be difficult to identify. The goal of this study
was to explore patient risk factors that were predictive of drug resistance in order to
help healthcare providers identify patients potentially at risk of DRTB [136].
In crude analyses, DRTB patients were more likely than drug-susceptible TB
patients to be younger, use illicit drugs (marijuana, inhalants, and crack cocaine), have
previously been treated for TB, and prefer to treat a family member in secret. After
controlling for these variables in multivariable analysis, only crack cocaine use remained
an independent predictor of DRTB. It is important to note that crack cocaine use may be
a proxy for more complex social variables that were not accounted for in this
preliminary study that need more attention in future studies, especially considering
that crack cocaine use was significantly associated with other adverse behavioral and
socioeconomic conditions, and the confidence intervals were wide showing substantial
variability.
Individuals who use illicit drugs present high-risk groups for having DRTB for
several reasons [17, 138]. First, illicit drug use (herein referred to as “drug use”)
challenges TB care from direct immune impairment [145, 146]. For example, crack
cocaine inhalation can weaken pulmonary function through suppressed alveolar
macrophage antimicrobial activity and cytokine production [146, 147]. Second, drug use
is embedded in adverse health and social factors that can affect patient loss to follow-
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up (i.e., treatment default) [133]. Several of these interconnected risk factors for DRTB
that make drug users a vulnerable population include alcohol abuse, homelessness, low
education and income, impoverished and crowded housing conditions, unfavorable
patient-provider relations, financial burdens of treatment, and limited access to health
services [4, 137-141]. The combination of immune impairment and treatment barriers
associated with drug use may increase risk for DRTB, although not all studies have
found an association [142, 144, 148].
Specifically, crack cocaine use among TB patients has previously been linked
with distrustful patient-provider relationships and non-adherence [141], leading to poor
treatment outcomes, patient loss to follow-up, and higher treatment costs, all of which
increases risk for DRTB [137, 147]. Studies that have shown an association between
DRTB and crack cocaine use also acknowledge other associations with race, low income
neighborhoods, and other co-morbidities [141]. In addition, the risk of transmission of
drug-resistant strains at crack houses may place crack users at increased risk of DRTB
[141]. In our study, the association between crack cocaine was independently
associated with DRTB, even after controlling for various other patient factors, but its
correlations with these characteristics suggests that it is still embedded in a larger
contextual model of risk. Overall, TB control efforts in Mexico may benefit from
ascertaining crack cocaine history as a risk assessment for DRTB, and conducting DST in
new and recurrent TB patients with a positive crack cocaine history.
Previous treatment for TB tends to be a strong predictor of drug resistance [135,
136], although this variable dropped out in our multivariable analysis. This may be due
to the fact that previously treated TB cases includes different “types” of patients,
including relapse cases (patients previously cured or treatment completed), patients
who began treatment but then abandoned it, and patients who failed initial treatment,
possibly because they were infected with a drug-resistant isolate [133]. Previously
treated cases are a heterogeneous group with respect to risk factors, such as low
income, alcohol abuse, HIV co-infection, inadequate TB knowledge, previous treatment
abandonment, herbal medication use, male sex, difficult access to hospital services, and
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poor supervision for adherence [149-151]. In addition, it is possible that accurate
reporting of prior treatment may be difficult to obtain due to patient’s fear of shame,
reprisals, or not being offered treatment, again. Future surveillance should separate
previously treated TB cases into the three sub-groups of relapse, treatment default, and
initial treatment failure, and explore risk factors specific to each group [133].
A strength of this study was that we screened all TB patients for drug resistance.
Additionally, our questionnaire assessed comprehensive information on individual,
clinical, household, and neighborhood variables, with broad measures of socioeconomic
characteristics. The questionnaire included a nationwide socioeconomic survey [53],
providing a standardized measure for comparative studies in other regions of Mexico.
The validation of co-morbidities and TB-related data through medical record reviews
helped to counter possible recall bias among participants. This exploratory secondary
analysis has several limitations, one of which was the small sample size of drug-resistant
cases, leading to wide confidence intervals in our final results. Additionally, participants
were recruited from a single public hospital in Monterrey that was a catchment site for
the MMA, so results may not be generalizable to patients that attend clinics in areas of
higher socioeconomic status, or in less urbanized areas throughout Mexico. As
mentioned above, the complexity of social and behavioral factors that influence DRTB
may not have been captured with our questionnaire, notably with factors that
predispose patients to drug use and consequently poor disease management. We
recognize the potential for residual confounding in our findings, such that if
confounding variables that influence DRTB were omitted or not accurately captured,
the inclusion of these variables in future models could diminish the magnitude of the
effect of crack cocaine use on DRTB that we reported. Importantly, this study focused
on patient risk factors and did not include community risk factors, such as the quality of
health care services. The exploratory nature of this study is recognized with crack
cocaine use a possible proxy for more complex interrelated risk factors, and our findings
can guide future work on DRTB in the MMA.
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Conclusion
DRTB is increasing in Mexico, especially along the U.S.-Mexico border, and
presents substantial challenges to TB care. Usual predictors of TB disease were not
associated with risk for drug resistance in this sample, and therefore might be
inadequate predictors of people at risk for drug resistance in the MMA. Crack cocaine
use, however, clearly distinguished drug-resistant from drug-susceptible TB patients
and may help identify higher risk individuals for prioritized DST. The correlations
between crack cocaine use and adverse behavioral and social conditions highlights the
co-existing risk factors for drug users, presenting a complex set of challenges for TB
prevention and treatment. In regions where DST is not routinely administered,
healthcare providers should consider testing for drug resistance in all new and
recurrent TB cases who have a positive history of crack cocaine use.
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CHAPTER 5. SUMMARY AND CONCLUSIONS
Summary of findings
This dissertation was an integration of detailed genetic and environmental data
to explore causes of TB disease variation in the MMA. The project addressed a complex
suite of risk factors for active TB and DRTB to better understand the variation in rates
across populations. The broader goal of this study was to explore potential reasons that
TB disparities have persisted among people of non-European descent, and to know
what role ancestry played in this persistence from genetic and social perspectives. To
our knowledge, no previous study has formally tested the association of genetic
ancestry with active TB. The key findings of the dissertation are summarized as follows.
Chapter 2 findings were based on a case-control study from individuals with
confirmed latent TB infection and active pulmonary TB. We carefully selected controls
to represent the source population of cases. Overall, we found no support for an
independent association between genetic ancestry and active TB status. The main
predictors for active TB included diabetes (OR 2.48, 95% CI: 1.0, 6.8),
single/divorced/separated status (OR 2.89, 95% CI: 1.3, 6.6), and not having a computer
in the home (OR 2.28, 95% CI: 1.0, 5.1). These correlates of TB disease support growing
recognition of the importance of assessing individual and social factors that are specific
to a population. The roots of TB disease disparities will be better understood by
assessing population-specific social conditions that affect individual-level exposures.
In Chapter 3, we addressed the need to investigate whether ancestry could
serve as a useful proxy for the genetic variants of risk of multifactorial disease across
the parental populations of admixed groups. Genetic associations between ancestry
and disease-causing alleles cannot be found under a one-time admixture model, so it is
important to know the admixture history of a population prior to conducting a disease
association study. Given our lack of an association between ancestry and TB status
described in Chapter 2, it was surprising that our sample did not fit a one-time
admixture model. Instead, the substantial genetic heterogeneity among 86% of
individuals was consistent with a more complex model of admixture, partially fleshed
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out by evidence of indigenous immigration and assortative mating based on European
ancestry and socioeconomic status. Given its wide range of variation in the MMA,
genetic ancestry has the potential to be informative about genetic differences in TB risk
between the parental populations. However, in our recent study of the correlates of
active pulmonary TB in the MMA, we found no association between TB-disease status
and genetic ancestry, suggesting that: 1) genetic differences in TB-causing alleles do not
exist between the ancestral populations that formed the Monterrey population, 2) any
genetic differences that do exist contribute proportionately little to variation in TB
disease compared to sociocultural factors, or 3) power was too low to detect existing
associations. In sum, results suggest that in countries throughout the Americas with
limited healthcare resources, public health strategies for disease prevention may be
more effective by addressing the social determinants that have larger effects on disease
disparities.
Finally, our analysis in Chapter 4 of DRTB in the MMA gave insight into an
important risk factor for DRTB. Even though typical risk factors for TB did not separate
drug-resistant from drug-susceptible cases, the use of crack cocaine was a robust
predictor of DRTB (OR 5.21, 95% CI: 1.33, 20.4). Given increasing rates of DRTB in
Mexico and along the U.S.-Mexico border, targeting higher risk patients for prioritized
drug susceptibility testing is useful for prevention and adapted treatment policies. The
fact that crack cocaine use is embedded in complex social factors related to treatment
barriers makes crack cocaine users a special population for TB treatment, and warrants
further attention on modified treatment policies for helping detect and cure DRTB.

Strengths and limitations
Several notable strengths of this study include the fact that all cases and
controls had confirmation of TB status, whether it was active pulmonary disease, latent
TB infection, or DRTB. Our careful selection of controls to reflect the source population
of cases was a critical component of a high-quality case-control study, even though this
meant that well-matched controls were harder to identify and recruit, leading to
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relatively small sample sizes for sub-analyses. Additional strengths of this dissertation
include our comprehensive assessment of individual and residential variables, many of
which were taken from Mexican surveys that can be used for future comparisons. Our
findings found population-specific predictors of active TB and DRTB that were unique to
the MMA. Lastly, our use of genomic data to test the effects of genetic ancestry on TB
status was novel.
Several limitations of this dissertation are important to note. Power may have
been limited due to small sample sizes within each chapter. TB is a complex disease,
and it is likely that we did not capture all environmental risk factors in the MMA, and
even those that we did collect may not have been perfectly measured. Lastly, our
findings may be limited to urban areas in developing countries and may be less
applicable for TB control efforts among rural populations.

Conclusions
In conclusion, we did not find an association with genetic ancestry and active TB
or DRTB. Diabetes, marital status, and computer ownership were the main predictors of
active pulmonary TB in our MMA sample. Crack cocaine use was a robust predictor of
DRTB among our subset of participants with drug resistant and drug sensitive
pulmonary TB disease. Overall, health, behavioral, and residential variables were the
main predictors of TB status in the MMA, despite variation in genetic ancestry
estimates throughout the population. It is long argued that genetic factors explain TB
variation between populations, but our results suggest that there is no support for a
genetic basis of disease risk that varies between parental populations that contributed
to the MMA, or that genetic effects are low compared to environmental factors.
Variation in TB rates across populations may be better understood by addressing
contextual factors of socioeconomic and health conditions that have larger effects on
active TB and DRTB susceptibility.
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APPENDIX A
SUPPLEMENTARY TABLES FOR CHAPTER 2
Supplementary Table A.1. Crude associations between active pulmonary TB and
individual characteristics (N=137)
Variable

Age in years
European genetic ancestry %*
Native American genetic ancestry % *
African genetic ancestry % *
Mean total pack years**
Second-hand smoke exposure (hours per
day)

Sex
Female
Male
Indigenous ethnicity
Indigenous heritage
Non-indigenous
Educational attainment
Less than primary through secondary
Commerical, high school, or higher
Principal lifetime employment
Professional, semi-professional, student
Non-professional or unemployed
Diabetes
No
Yes
History of alcohol problems
No
Yes
Asthma
No
Yes
Hypertension
No
Yes
Knowledge of TB airborne transmission
No
Yes
Knowledge that TB is curable
No
Yes
Marijuana use
No
Yes

Cases
(n = 97)
Mean ± s.d.
44.8 ± 16.9
37.2 ± 10.8
55.7 ± 12.3
7.1 ± 2.3

Controls
(n = 40)
Mean ± s.d.
41.4 ± 12.9
39.4 ± 12.4
53.1 ± 13.1
7.5 ± 2.4

Odds Ratio
(95% CI)

p-value

0.25
0.32
0.30
0.41

2.7 ± 6.1

1.01 (0.99, 1.04)
0.16 (0.004, 6.12)
6.17 (0.20, 186.2)
0.01 (<0.01,
>999.9)
1.03 (0.99, 1.08)

6.7 ± 15.8
1.4 ± 3.6

0.9 ± 2.2

1.06 (0.92, 1.23)

0.41

N (%)

N (%)

44 (45.4)
53 (54.6)

15 (37.5)
25 (62.5)

Reference
0.72 (0.34, 1.54)

-0.40

18 (18.6)
79 (81.4)

10 (25.0)
30 (75.0)

0.68 (0.28, 1.65)
Reference

0.41
--

70 (72.2)
27 (27.8)

20 (50.0)
20 (50.0)

2.35 (1.1, 5.0)
Reference

0.03
--

26 (26.8)
71 (73.0)

18 (45.0)
22 (55.0)

Reference
2.24 (1.04, 4.82)

-0.04

69 (71.1)
28 (28.9)

34 (85.0)
6 (15.0)

Reference
2.42 (0.92, 6.38)

-0.07

84 (86.6)
13 (13.4)

39 (97.5)
1 (2.5)

Reference
6.04 (0.76, 47.79)

-0.06

3 (3.1 )

1 (2.5)

Reference
1.25 (0.13, 12.34)

-0.85

9 (9.3)

7 (17.5)

Reference
0.48 (0.17, 1.40)

-0.17

21 (21.7)
76 (78.4)

3 (7.5)
37 (92.5)

3.41 (0.96, 12.16)
Reference

0.06
--

5 (5.2)
91 (94.8)

3 (7.5)
37 (92.5)

0.68 (0.15, 2.98)
Reference

0.61
--

86 (88.7)
11 (11.3)

37 (92.5)
3 (7.5)

Reference
1.58 (0.42, 5.98)

-0.50
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0.12

Stimulant use (cocaine, methamphetamine)
No
Yes
Injected drug use
No
Yes
Inhalant use
No
Yes
Ever had BCG vaccination
No, don’t know
Yes

85 (87.6)
12 (12.4)

40 (100.0)
0 (0.0)

Reference
N/A***

-N/A

92 (94.9)
5 (5.2)

40 (100.0)
0 (0.0)

Reference
N/A***

-N/A

93 (95.9)
4 (4.1)

40 (100.0)
0 (0.0)

Reference
N/A***

-N/A

18 (18.6)
79 (81.4)

5 (12.8)
35 (87.5)

1.60 (0.55, 4.64)
Reference

0.39
--

*Individual genetic ancestry estimated from approximately 25,000 single nucleotide
polymorphisms (SNPs)
**Total pack years calculation: (#cigarettes per day * years of smoking)/20
***Insufficient data for approximation
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Supplementary Table A.2. Crude associations between active pulmonary TB and social
characteristics (N=137)
Variable

Controls
(n = 40)
Mean ± s.d.
2.5 ± 1.4
5.6 ± 2.8
164.4 ± 59.8

Odds Ratio
(95% CI)

p-value

Lifetime household crowding*
Total number of windows in the house
Current socioeconomic status**

Cases
(n = 97)
Mean ± s.d.
2.3 ± 1.6
4.8 ± 2.7
151.2 ± 61.6

0.93 (0.74, 1.17)
0.91 (0.79, 1.03)
1.0 (0.99, 1.00)

0.55
0.14
0.25

Lifetime socioeconomic status**

134.6 ± 66.3

145.9 ± 72.9

1.0 (0.99, 1.00)

0.38

Travel time to UANL Hospital (minutes)

67.8 ± 71.6

Household income per 15 days (pesos)
<2,000
2,001 – 5,999
6,000 or higher
Marital status
Single, divorced, separated, widow
Married, free union
Current socioeconomic status**
Highest, Upper-Middle
Middle
Lowest, Low-Middle
Windows in the bedroom
No
Yes
Running water inside home
No
Yes
Known close contact with someone with TB
No, don’t know
Yes
Frequency of going to bed hungry (lifetime)
Never
Sometimes, frequently
Number of rooms in house (not including
bathrooms, hallways, patios, rooftops)**
1-4
5 or more
Number of complete bathrooms with shower
and toilet exclusive to members of household**
0
1 or more
Presence of functioning shower in the house**
No
Yes
Number of lights in house (on ceiling, walls, floor
lamps, desk lamps, etc.)**
0-5
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54.0 ± 30.8

1.01 (1.00, 1.01)

0.24

N (%)

N (%)

32 (35.2)
45 (49.5)
14 (15.4)

12 (30.8)
19 (48.7)
8 (20.5)

1.54 (0.51, 4.55)
1.35 (0.49, 3.76)
Reference

0.43
0.53
--

50 (51.6)
47 (48.5)

12 (30.0)
28 (70.0)

2.48 (1.13, 5.44)
Reference

0.02
--

25 (25.8)
52 (53.6)
20 (20.6)

14 (35.0)
21 (52.5)
5 (12.5)

Reference
1.39 (0.61, 3.17)
2.24 (0.69, 7.28)

-0.44
0.18

11 (11.3)
86 (88.7)

0 (0)
40 (100.0)

N/A***
Reference

N/A
--

12 (12.4)
85 (87.6)

6 (15.0)
34 (85.0)

0.80 (0.28, 2.30)
Reference

0.68
--

51 (52.6)
46 (47.4)

17 (42.5)
23 (57.5)

Reference
0.67 (0.32, 1.40)

-0.28

76 (78.4)
21 (21.7)

31 (77.5)
9 (22.5)

Reference
0.95 (0.39, 2.31)

-0.91

53 (55.2)
43 (44.5)

21 (52.5)
19 (47.5)

1.12 (0.53, 2.34)
Reference

0.77
--

8 (8.3)
88 (91.7)

1 (2.5)
39 (97.5)

3.54 (0.43, 29.3)
Reference

0.24
--

11 (11.5)
85 (88.5)

1 (2.5)
39 (97.5)

5.05 (0.63, 40.48)
Reference

0.09
--

31 (32.3)

10 (25.0)

1.40 (0.48, 4.03)

0.54

6-10
11 or more
Material of household floor**
Earth or cement
Other (e.g., tile)
Number of cars at house (excluding taxis)**
0
1
2 or more
Number of functioning color televisions in
house**
0
1
2 or more
Number of personal computers**
0
1 or more
Presence of gas or electric stove in house**
No
Yes
Educational attainment of highest income earner
in household
Less than primary through secondary
Commerical, high school, or higher
Residence as a child
Ranch or small town
City
Normal mode of transportation
Car
Public bus
Other (taxi, metro, bike, moto)
Factory within 10 blocks of house
No
Yes
Residence in MMA municipalities (SES
groupings based on geospatial analysis)
San Pedro, San Nicolás (high)
Monterrey, Guadalupe, García, Santa
Catarina (medium, medium-low)
Apodaca, Escobedo, Juarez (very low)
Outside the MMA
Ever been a resident in prison
No
Yes

45 (46.9)
20 (20.8)

21 (15.4)
9 (22.5)

0.96 (0.38, 2.47)
Reference

0.94
--

58 (60.4)
38 (39.6)

23 (57.5)
17 (42.5)

1.13 (0.53, 2.39)
Reference

0.75
--

49 (51.0)
31 (32.3)
16 (16.7)

19 (47.5)
14 (35.0)
7 (17.5)

1.13 (0.40, 3.17)
0.97 (0.33, 2.88)
Reference

0.82
0.95
--

2 (2.1)
29 (30.2)
65 (67.7)

1 (2.5)
8 (20.0)
31 (77.5)

0.95 (0.08, 10.93)
1.73 (0.71, 4.22)
Reference

0.97
0.23
--

59 (62.1)
36 (37.9)

17 (42.5)
23 (57.5)

2.22 (1.05, 4.70)
Reference

0.04
--

2 (2.1)
94 (70.6)

1 (2.5)
39 (97.5)

0.83 (0.07, 9.42)
Reference

0.88
--

65 (68.9)
28 (30.1)

20 (50.0)
20 (50.0)

2.32 (1.1, 5.0)
Reference

0.03
--

31 (32.0)
66 (68.0)

9 (22.5)
31 (77.5)

Reference
0.62 (0.26, 1.46)

-0.27

23 (23.7)
63 (65.0)
11 (11.3)

11 (27.5)
26 (65.0)
3 (7.5)

Reference
1.16 (0.50, 2.72)
1.75 (0.41, 7.58)

-0.73
0.45

74 (76.3)
23 (23.7)

32 (80.0)
8 (20.0)

Reference
1.24 (0.50, 3.07)

-0.64

8 (8.3)
57 (58.8)

6 (15.0)
20 (50.0)

Reference
2.14 (0.66, 6.91)

-0.20

19 (19.6)
13 (13.4)

10 (25.0)
4 (10.0)

1.43 (0.39, 5.26)
2.24 (0.52, 11.4)

0.59
0.26

86 (88.7)
11 (11.3)

39 (97.5)
1 (2.5)

Reference
5.00 (0.62, 40.00)

-0.10
(0.18
fishers)

Ever been a resident of a homeless shelter
No
Yes

95 (97.9)
2 (2.1)

40 (100.0)
0 (0.0)

Reference
N/A***

-N/A

Ever been a resident in a nursing home
No
Yes

97 (100.0)
0 (0.0)

40 (100.0)
0 (0.0)

Reference
N/A***

-N/A
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*Household crowding index: Number of people living in house / Number of rooms for sleeping ;
higher numbers mean more crowding, any number over 1.0 is considered crowding
**Taken from the AMAI Mexican socioeconomic 10-item survey (2008)
***Insufficient data for approximation

Supplementary table A.3. Significant associations of ‘computer in the home’ with
socioeconomic variables
Variable
Educational attainment
Less than primary through secondary
Commerical, high school, or higher
Principal lifetime employment
Professional, semi-professional, student
Non-professional or unemployed
Household income per 15 days (pesos)
<2,000
2,001 – 5,999
6,000 or higher
Current socioeconomic status**
Highest, Upper-Middle
Middle
Lowest, Low-Middle
Educational attainment of highest income
earner in household
Less than primary through secondary
Commerical, high school, or higher

No Computers
(n = 76)

1+ Computers
(n = 59)

p-value

64 (84.2)
12 (15.8)

25 (42.4)
34 (57.6)

<0.0001

11 (14.5)
65 (85.5)

33 (55.9)
26 (44.1)

<0.0001

35 (48.0)
43 (46.6)
4 (5.5)

7 (12.7)
30 (54.6)
18 (32.7)

<0.0001

5 (6.6)
47 (61.8)
24 (31.6)

34 (57.6)
25 (42.4)
0 (0.0)

<0.0001

60 (81.1)
14 (18.9)

24 (41.4)
34 (58.6)

<0.0001
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APPENDIX B
SUPPLEMENTARY TABLE FOR CHAPTER 4

Supplementary table B.1. Associations of crack cocaine use among drug-resistant and
drug-sensitive TB cases with individual and social factors (N=95)
Variable

No crack
cocaine use
N=85
45.5 ± 17.7
30.9 ± 11.5
60.9 ± 12.9
8.1 ± 3.0
61 ± 16.1

Age in years
European genetic ancestry %
Native American genetic ancestry %
African genetic ancestry %
Mean total pack years*
Sex
Female
Male
Self-reported indigenous ethnicity
Indigenous heritage
Non-indigenous
Educational attainment
Less than primary through secondary
Commerical, high school, or higher
Principal lifetime employment
Professional, semi-professional, student
Non-professional or unemployed
Diabetes
No
Yes
History of alcohol problems
No
Yes
Asthma
No
Yes
Hypertension
No
Yes
Hepatitis
No
Yes
Marijuana use
No
Yes
Methamphetamine use
No
Yes
Injection drug use
63

Yes, history of crack
cocaine use
N=10
39.4 ± 8.2
35.9 ± 7.1
54.5 ± 7.9
9.7 ± 2.3
12.1 ± 13.7
N (%)

p-value

0.07
0.21
0.15
0.14
0.22

41 (48.2)
44 (51.8)

3 (30.0)
7 (70.0)

0.33

16 (18.2)
69 (81.2)

1 (10.0)
9 (90.0)

0.68

58 (68.2)
27 (31.8)

10 (100.0)
0 (0.00)

0.058

25 (29.4)
60 (70.6)

0 (0.0)
10 (100.0)

0.058

59 (69.4)
26 (30.6)

7 (70.0)
3 (30.0)

1.0

78 (91.8)
7 (8.2)

5 (50.0)
5 (50.0)

0.003

83 (97.7)
2 (2.4)

10 (100.0)
0 (0.0)

1.0

76 (89.4)
9 (10.6)

10 (100.0)
0 (0.0)

0.59

83 (97.7)
2 (2.4)

8 (80.0)
2 (20.0)

0.05

82 (96.5)
3 (3.5)

3 (30.0)
7 (70.0)

<0.0001

85 (100.0)
0 (0.0)

7 (70.0)
3 (30.0)

<0.0001

No
Yes
Inhalant use
No
Yes
Previously treated for TB
No (<1 month of treatment, ‘new case’)
Yes (≥1 month of treatment, ‘previously treated’)
Knowledge of TB airborne transmission
No
Yes
Knowledge that TB is curable
No
Yes
Social stigma by preference to treat a family
member with TB in secrecy
No
Yes
Ever saw or felt discrimination against TB
No
Yes
Ever felt fear related to TB
No
Yes
BCG vaccination
No
Yes
Close contact with a TB patient
No
Yes
Place first learned about TB
Health clinic, doctors, hospital
Other (family, public media, school, books)
Use of alternative remedies/therapies to treat TB
No
Yes
Travel time to UANL Hospital (minutes)
Marital status
Single, divorced, separated, widow
Married, free union
Household income per 15 days (pesos)
<2,000
2,001 – 5,999
6,000 or higher
Frequency of going to bed hungry (lifetime
prevalence)
Never
Sometimes, frequently
Running water inside home
No
Yes
Windows in bedroom
No

85 (100.0)
0 (0.0)

6 (60.0)
4 (40.0)

<0.0001

84 (98.8)
1 (1.2)

7 (70.0)
3 (30.0)

0.003

22 (25.9)
63 (74.1)

1 (10.0)
9 (90.0)

0.44

18 (21.2)
67 (78.8)

1 (10.0)
9 (90.0)

0.68

5 (5.9)
80 (94.1)

0 (0.0)
9 (100.0)

1.0

72 (84.7)
13 (15.3)

7 (70.0)
3 (30.0)

49 (59.8)
33 (40.2)

7 (70.0)
3 (30.0)

0.73

40 (47.1)
45 (52.9)

3 (30.0)
7 (70.0)

0.50

16 (18.8)
69 (81.2)

1 (10.0)
9 (90.0)

0.68

43 (50.6)
42 (49.4)

8 (80.0)
2 (20.0)

0.10

62 (72.9)
23 (27.1)

10 (100.0)
0 (0.0)

0.11

65 (92.9)
5 (7.1)
65 ± 65

10 (100.0)
0 (0.0)
57 ± 30

1.0

42 (49.4)
43 (50.6)

7 (70.0)
3 (30.0)

0.32

25 (31.3)
41 (51.3)
14 (17.5)

5 (55.6)
4 (44.4)
0 (0.00)

0.28

67 (78.8)
18 (21.2)

7 (70.0)
3 (30.0)

9 (10.6)
76 (89.4)

3 (30.0)
7 (70.0)

0.11

7 (8.2)

4 (40.0)

0.01

0.36

0.50

0.69
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Yes
Normal mode of transportation
Personal car
Other (public bus, metro, taxi, bike)
Residence in MMA municipalities (SES groupings
based on geospatial analysis)
San Pedro, San Nicolás (high)
Monterrey, Guadalupe, García, Santa Catarina
(medium, medium-low)
Apodaca, Escobedo, Juarez (very low)
Outside the MMA
Ever been a resident in prison
No
Yes
Ever been a resident of a homeless shelter
No
Yes
Number of rooms in house (not including
bathrooms, hallways, patios, rooftops)**
1-4
5 or more
Number of complete bathrooms with shower and
toilet exclusive to members of household**
0
1 or more
Presence of functioning shower in the house**
No
Yes
Number of lights in house (on ceiling, walls, floor
lamps, desk lamps, etc.)**
0-5
6-10
11 or more
Material of household floor**
Earth or cement
Other (e.g., tile)
Number of cars at house (excluding taxis)**
0
1
2 or more
Number of functioning color televisions in
house**
0
1
2 or more
Number of personal computers**
0
1 or more
Presence of gas or electric stove in house**
No
Yes
Educational attainment of highest income earner

78 (91.8)

6 (60.0)

23 (27.1)
62 (72.9)

0 (0.0)
10 (100.0)

0.11

8 (9.4)
49 (57.7)

0 (0.0)
7 (70.0)

0.62

18 (21.2)
10 (11.8)

1 (10.0)
2 (20.0)

78 (91.8)
7 (8.2)

7 (70.0)
3 (30.0)

0.07

84 (98.8)
1 (1.2)

9 (90.0)
1 (10.0)

0.20

44 (51.8)
41 (48.2)

7 (77.9)
2 (22.2)

0.17

7 (8.2)
78 (91.8)

1 (11.1)
8 (88.9)

0.57

9 (10.6)
76 (89.4)

2 (22.2)
7 (77.8)

0.28

22 (25.9)
44 (51.8)
19 (22.4)

7 (77.8)
1 (11.1)
1 (11.1)

0.007

49 (57.7)
36 (42.4)

7 (77.8)
2 (22.2)

0.30

40 (47.1)
30 (35.3)
15 (17.7)

7 (77.8)
1 (11.1)
1 (11.1)

1 (1.2)
23 (27.1)
61 (71.8)
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0.26

1 (11.1)
5 (55.6)
3 (33.3)

0.02

50 (59.5)
34 (40.5)

8 (88.9)
1 (11.1)

0.15

2 (2.4)
83 (97.7)

0 (0.0)
9 (100.0)

1.0

in household**
Less than primary through secondary
55 (67.1)
8 (88.9)
Commerical, high school, or higher
27 (32.9)
1 (11.1)
Current socioeconomic status***
Highest, Upper-Middle
24 (28.2)
1 (10.0)
Middle
48 (56.5)
3 (30.0)
Lowest, Low-Middle
13 (15.3)
6 (60.0)
*Total pack years calculation: (#cigarettes per day * years of smoking)/20
**Individual questions taken from the AMAI Mexican socioeconomic 10-item survey (2008)
***Compiled index of the AMAI Mexican socioeconomic 10-item survey (2008)

66

0.27

0.01

APPENDIX C
LETTER OF ACCEPTANCE FOR COLLABORATION AT UANL
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APPENDIX D
PROTOCOL FOR DNA EXTRACTION
Name: ___________________________
Date: ____________________________
Extractions: ______________________
Puregene DNA Isolation Kit Protocol
Modified by Molecular Epidemiology Lab, MSKCC
Used by Dr. Keith Hunley’s Lab in the UNM Department of Anthropology
DNA Isolation from Buccal Cells in Mouthwash
Expected DNA Yield Range: 4 µg – 40 µg, Mean: 16 µg
Estimated Time to Process Four Samples: 2hrs, 45 mins – 3hrs
Buccal Cell collection and Cell Lysis
1. Dispense 10 ml Original Mint Scope Mouthwash into a 50 or 15 ml tube.
2. Collect buccal cells by swishing orally the 10 ml of mouthwash for 1 minute (time it if needed)
and spitting back into the 50 ml tube.
Notes: i) For best results, wait at least one hour after eating or drinking to collect buccal cells.
ii) Buccal cells are stable at room temperature for at least 7 days in the mouthwash
solution if mouthwash contains ethanol up to 15%; otherwise add 2 ml of 70% ethanol
solution to collected sample. That increases storage time while controlling for bacterial
and fungi growth
iii) If samples are frozen, allow to thaw to room temperature (1-2 hours)
3. Centrifuge at 2,000 x g (4,000 rpm in lab centrifuge) for 10 minutes to concentrate the cells.
Immediately pour off supernatant leaving behind 100 µl of residual liquid. Loose pellets will
result if samples sit too long after centrifugation. Repeat this step if that occurs and pour
supernatant immediately after spinning.
4. Vortex vigorously to resuspend the cells in the residual supernatant (up to 1 minute may be
necessary).
5. Add 3 ml Cell Lysis Solution to the resuspended cell and vortex 5 seconds at medium speed
to maximize contact between cells and Cell Lysis Solution.
6. Add 15 µl of Proteinase K (20 mg/ml) and incubate at 56ºC for 1 hour.
Protein Precipitation
1. Cool sample to room temperature. (10-15 minutes)
2. Add 1 ml Protein Precipitation Solution to the cell lysate.
3. Vortex samples at high speed for 20 seconds to mix the Protein Precipitation Solution
uniformly with the lysate.
4. Place tube in an ice bath for 10 minutes to ensure a tight pellet in Step 5 below.
5. Centrifuge at 2,000 x g (4,000 rpm in lab centrifuge) for 10 minutes. The precipitated proteins
should form a tight, green pellet.
DNA Precipitation
1. Pour the supernatant containing the DNA (leaving behind the precipitated protein pellet) into a
clean 50 or 15 ml tube containing 3 ml 100% Isopropanol (2-propanol) and 5 µl Glycogen
Solution (20 mg/ml). *(Once you add the glycogen you MUST finish entire protocol.)
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2. Mix the sample by inverting gently 50 times and keep tube at room temperature for at least 5
minutes.
3. Centrifuge at 2,000 x g (4,000 rpm in lab centrifuge) for 10 minutes. The DNA may or may
not be visible as a small white pellet, depending on yield.
4. Pour off the supernatant and drain tube briefly on clean absorbent paper. (Drain upside down
on absorbent paper for a few minutes.) Add 3 ml cold 70% Ethanol by gently pipetting down the
side of the tube to wash the DNA pellet. Do not shake or agitate the tube.
5. Centrifuge at 2,000 x g (4,000 rpm in lab centrifuge) for 3 minutes. Carefully pour off the
Ethanol.
6. Invert and drain tube on clean absorbent paper and allow to air dry for 1-2 hours. Leave space
so air can help evaporate the ethanol. ALL the ethanol MUST be completely gone.
DNA Hydration
1. Add 200 µl of DNA Hydration Solution. Vortex briefly and spin down the tubes on “quick
run” (about 800 rpm) in lab centrifuge.
2. Allow DNA to rehydrate by incubating at 65 ºC for 1 hour.
3. For storage, sample may be vortexed, centrifuged briefly and transferred to a 1.5 or 2 ml tube.
Store DNA at 2-8ºC. For long term storage, store at -20ºC or -80ºC.
Reading the DNA Results
1. Can read DNA yield at the 260/280 ratio after waiting 1 night of DNA at room temperature
in hydration solution on a rotator (shaken gently).
a. Want 260/280 ratio between 1.6-1.8. If > 1.8 then getting too much residual alcohol
and phenols. If < 1.6 then bacteria or some other contaminants in sample.
b. For DNA, want a nucleic acid concentration of minimum of 400 (if you are getting
super high yields, e.g., >1,000, it could be indicative of infection by bacteria or
fungus).
2. When prepping the nanodrop, use the SAME hydration solution to “blank” as is in the
samples. Use only 2 μl of solution to read nanodrop
a. Nanodrop machine should be re-calibrated every year
b. Check results page- “Factor” should be at 50.0
c. Want 260 to be similar for samples, want 280 to be similar for samples
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APPENDIX E
QUESTIONNAIRE FOR FACE-TO-FACE INTERVIEWS (ENGLISH VERSION)
“The Effects Genetic Ancestry and Socio-Cultural Factors on the Susceptibility of Active
Tuberculosis in Mexico”
Questionnaire: Face-to-face interview form
GENERAL INFORMATION

Participant Name: ___________________________________________________________
Medical record number (UANL): _______________________________________________
Participant ID#: _______________________________________
Participant’s Phone Number: _____________________________
Interviewer Name: _____________________________________
Date of interview: ___________________ (mm/dd/yy)
Patient registered clinic:
___________________________________________________________
Time interview began: _______________ Time interview finished: ______________
Researcher validated:
Type of participation:

[ ] Latent

[ ] Active

[ ] Unknown

Date of diagnosis: __________ year or _______ age
Type of TB:

[ ] Pulmonary

Drug-resistant:

[ ] Yes

[ ] Other: __________________
[ ] No

[ ] Unknown

SOCIOECONOMIC AND DEMOGRAPHIC INFORMATION

Sex:

[ ] Female

[ ] Male

In what month and year were you born? ________________ (mm/yy)
How old are you now? _______ (years) (1)
What is your current marital status? (1)
[ ] Civil union
[ ] Married
[ ] Widowed
[ ] Divorced
[ ] Separated
[ ] Single
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[ ] Don’t Know (1)

What was the highest level of school that you completed?
[ ] No studies
[ ] Primary incomplete
[ ] Primary completed
[ ] Middle school incomplete
[ ] Middle school complete
[ ] Commercial degree
[ ] Technical degree
[ ] High school incomplete
[ ] High school complete
[ ] Bachelors incomplete
[ ] Bachelors complete
[ ] Specialist, Masters degree
[ ] Doctoral degree
[ ] Don’t know /no answer
Where are you from? __________________________ (12) (city)
Currently, do you live in Monterrey? [ ] Yes

[ ] No

If “yes,” how much time have you lived in Monterrey? (1)
[ ] ____ years
If “no,” in what locality do you live? (1;2)
City: _________________________
State: _________________________
Country: _______________________
[ ] N.R.
When you were younger, we will say until around 12 years old, did you live the majority of the
time on a ranch, in a pueblo/small town, or in a city? (1)
[ ] Ranch
[ ] Pueblo/small town
[ ] City
[ ] N.R.
What is your current home address?
________________________________________________________________________
Do you consider yourself indigenous? (10)
[ ] Yes
[ ] No
[ ] N.R.
[ ] Don’t know
Do you speak an indigenous language? [ ] Yes
[ ] No (10)
If “yes,” which language?
[ ] Nauhuatl
[ ] Maya
[ ] Zapoteco
[ ] Mixteco
[ ] Tzotzil/tzetzal
[ ] Otomi
[ ] Totonaca
[ ] Mazateco
[ ] Chol
[ ] Huasteco [ ] Chinanteco
[ ] Mazahua
[ ] Mixe
[ ] Other (specify): ______________________
Do your parents or other family members speak (or did they speak) an indigenous language?
[ ] Yes [ ] No
If “yes,” which language?
[ ] Nauhuatl
[ ] Maya
[ ] Tzotzil/tzetzal
[ ] Otomi

[ ] Zapoteco
[ ] Totonaca
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[ ] Mixteco
[ ] Mazateco

[ ] Chol
[ ] Mixe

[ ] Huasteco [ ] Chinanteco
[ ] Mazahua
[ ] Other (specify): ______________________

Are your parents from Mexico? [ ] Yes

[ ] No

If “no,” where is your _______________ from? __________________ (country)
Are your grandparents on both sides from Mexico?

[ ] Yes

[ ] No

If “no,” where is your ________________ from? _______________ (country)
Are your greatgrandparents on both sides from Mexico? [ ] Yes

[ ] No

If “no,” where is your ________________ from? _______________ (country)

Are you currently employed?
[ ] YES
[ ] NO
If “YES,” what is your current occupation?
_________________________________________
How many years have you had this occupation? _________ years
What was your occupation before this job?
_________________________ occupation
For how many years did you have this occupation? ___________ years
What type of work have you had for most of your life? (International Labor Organization)
[ ] Professional (manager, senior officials, professionals)
[ ] Semi-professional (technicians, office workers, skilled laborers)
[ ] Nonprofessional (service and sales workers, farmers, unskilled workers,
homemakers)
SOCIOECONOMIC LEVEL NOW

What is the total number of rooms in the house, bedrooms? Please don’t include bathrooms, half
bathrooms, hallways, courtyards, or rooftops. (5)
Response
Points
[ ]1
0
[ ]2
0
[ ]3
0
[ ]4
0
[ ]5
8
[ ]6
8
[ ] 7 or more
14
How many bathrooms are complete with a shower and W.C. are exclusive to the use of the
members of your household? (5)
Response
Points
[ ]0
0
[ ]1
13
[ ]2
13
[ ]3
31
[ ] 4 or more
48
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In the house, is there a shower that functions in one of the bathrooms? (5)
Response
Points
[ ] No
0
[ ] Yes
10
Counting all the sources used to illuminate your house, including those on the ceiling, walls and
floor lamps, desk, etc., tell me, how many lights are there in your house? (5)
Response
Points
[ ] 0-5
0
[ ] 6-10
15
[ ] 11-15
27
[ ] 16-20
32
[ ] 21 or more
46
Is the floor of your house predominately earth, cement, or of another type of finish? (5)
Response
Points
[ ] Earth or cement
0
[ ] Another type of material or finish 11
What type? _________________
How many cars do you own, excluding taxis, do you have at home? (5)
Response
Points
[ ]0
0
[ ]1
22
[ ]2
41
[ ] 3 or more 58
How many televisions (color) that are functioning do you have en your house? (5)
Response
Points
[ ]0
0
[ ]1
26
[ ]2
44
[ ] 3 or more 58
How many personal computers, including desk tops, lap-tops, are running in your house? (5)
Response
Points
[ ]0
0
[ ]1
17
[ ] 2 or more 29
In your house, is your stove gas or electric? (5)
Response
Points
[ ] Not gas or electric 0
[ ] Yes gas or electric 20
If its not gas or electric, what type of stove is it? ______________
If you use (or have used) wood, for how long? ________________
Thinking about the person that is the major income earner for the house, what was the highest
level of school that he/she completed? (5)
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Response
[ ] No studies
[ ] Primary incomplete
[ ] Primary completed
[ ] Middle school incomplete
[ ] Middle school complete
[ ] Commercial degree
[ ] Technical degree
[ ] High school incomplete
[ ] High school complete
[ ] Bachelors incomplete
[ ] Bachelors complete
[ ] Specialist, Masters degree
[ ] Doctoral degree
[ ] Don’t know /no answer

Points
0
0
22
22
22
38
38
38
38
52
52
72
72

Table of points per level:
Level
Points
E
Until 60
D
61-101
D+
102-156
C
157-191
C+
192-241
A/B
242 and more

Research calculated AMAI SES:
______ Total Points
______ Final Level

Approximately what is the 15-day salary (income) total in pesos that is earned by your house? (3)
[ ] Less than 2,000
[ ] 2,001-5,999
[ ] 6,000-9,999
[ ] 10,000-13,999
[ ] 14,000-17,999
[ ] 18,000 or more
[ ] N.R.
[ ] Don’t know
What type of health insurance do you have?
[ ] None
[ ] IMSS
[ ] Marina/Defensa
[ ] ISSSTE (public)
[ ] ISSSTE Estatal
[ ] Seguro Popular (SSA)
[ ] Pemex
[ ] Servicio Médico de la Universidad (UANL)
[ ] Private
[ ] Other Institution (specify): _____________________________
[ ] N.R.
[ ] Don’t know
What socioeconomic level did your parents have when you lived with them (when you were
growing up)?
[ ] Low resources
[ ] Medium resources
[ ] High resources
[ ] N.R.
HOUSING QUESTIONS NOW

Thinking in the house where you are living now:
Do you live in house that you:
_____

[ ] own

[ ] rent
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[ ] is your family’s

[ ] other:

For how many years have you lived there? _________ years
How many people live with you- including kids and adults? _________
Of these people that live with you, how many of them work and receive a salary? ______ people
How many rooms in the house are used to sleep? _________ rooms to sleep (1)
Does the house have a place to cook? (1)
[ ] Yes
[ ] No
If “Yes,” for what other purposes is the space used for?
[ ] The place is only for cooking
[ ] Other uses of the space: _______________________________________
[ ] Don’t know
Approximately how many windows are in the house? __________ total windows
Does your bedroom have windows? (9)

[ ] Yes

[ ] No

If “yes,” how many? _________
How many hours in the day are the windows open? (mark all that apply)
[ ] _____ hours during the winter
[ ] _____ hours during the summer
[ ] Don’t know
How is your house heated?
[ ] Gas
[ ] Electricity
[ ] Coal
[ ] Wood furnace
[ ] Other: ________________________________
[ ] N.R.
[ ] No heater in house
What material are the majority of the walls of your home made out of? (1)
[ ] Cardboard sheet
[ ] Palm or bamboo or Carrizo
[ ] Embarro o bajareque
[ ] Wood
[ ] Asbestos sheet or metallic sheet
[ ] Adobe
[ ] Stone, brick, cement block
[ ] N.R.
[ ] Don’t know
Do you have a refrigerator in your house? (9)
[ ] YES
[ ] NO
[ ] Don’t know
Does your house have indoor running water? (1)
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[
[
[
[

] Yes, inside the house
] Yes, outside the house but in the same area
] No
] N.R.

Is there a factory or industry less than 10 blocks from your house? (9) [ ] Yes
N.R.

[ ] No [ ]

If “yes,” what does the factory produce?
[ ] Cement
[ ] Metals (iron, copper, bronze)
[ ] Beer
[ ] Soda (Coca-Cola, Pepsi)
[ ] Food (Bimbo, Cookies)
[ ] Other: _______________________
With what frequency can you see or smell pollution from this factory?
[ ] Never o a few times each year
[ ] A few times each month
[ ] A few times each week
[ ] Ever day
How long does it take you to travel to this hospital? _______ [ ] hours
minutes

_______ [ ]

Researcher calculated total minutes: _________ minutes
How do you normally travel around Monterrey?
[ ] Public bus
[ ] Car
[ ] Taxi
[ ] Metro
[ ] Motorbike
[ ] Walk
[ ] Bicycle
[ ] Other: ______________________

SOCIOECONOMIC LEVELS IN THE PAST

In the 5-10 years previous to the TB diagnosis (or if you have never had TB, in the 5-10
years previous to your positive TB skin test) have you changed your house (living
situation)?
[ ] Si
[ ] No
If “yes,” how many times have you changed your house in the 5-10 years before you had
the TB diagnosis (or if you never had TB, in the 5-10 years before your positive test)?
__________ times
If “yes,” please think about the house where you lived the majority of the time around the
5-10 years before you had the TB diagnosis (or if you never had TB, 5-10 years before your
positive test):
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What material was the majority of the walls of your home made out of? (1)
[ ] Cardboard sheet
[ ] Palm or bamboo or Carrizo
[ ] Embarro o bajareque
[ ] Wood
[ ] Asbestos sheet or metallic sheet
[ ] Adobe
[ ] Stone, brick, cement block
[ ] N.R.
[ ] Don’t know
Did you have a refrigerator in your house? (9)
[ ] YES
[ ] NO
[ ] Don’t know
Did your house have indoor running water? (1)
[ ] Yes, inside the house
[ ] Yes, outside the house but in the same area
[ ] No
[ ] N.R.
What was the total number of rooms in the house, bedrooms? Please don’t include bathrooms,
half bathrooms, hallways, courtyards, or rooftops. (5)
Response
Points
[ ]1
0
[ ]2
0
[ ]3
0
[ ]4
0
[ ]5
8
[ ]6
8
[ ] 7 or more
14
How many bathrooms were complete with a shower and W.C. were exclusive to the use of the
members of your household? (5)
Response
Points
[ ]0
0
[ ]1
13
[ ]2
13
[ ]3
31
[ ] 4 or more
48
In the house, was there a shower that functioned in one of the bathrooms? (5)
Response
Points
[ ] No
0
[ ] Yes
10
Counting all the sources used to illuminate your house, including those on the ceiling, walls and
floor lamps, desk, etc., tell me, how many lights were there in your house? (5)
Response
Points
[ ] 0-5
0
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[
[
[
[

] 6-10
15
] 11-15
] 16-20
] 21 or more

27
32
46

Was the floor of your house predominately earth, cement, or of another type of finish? (5)
Response
Points
[ ] Earth or cement
0
[ ] Another type of material or finish 11
What type? _________________
How many cars did you own, excluding taxis, did you have at home? (5)
Response
Points
[ ]0
0
[ ]1
22
[ ]2
41
[ ] 3 or more 58
How many televisions (color) that were functioning did you have in your house? (5)
Response
Points
[ ]0
0
[ ]1
26
[ ]2
44
[ ] 3 or more 58
How many personal computers, including desk tops, lap-tops, were running in your house? (5)
Response
Points
[ ]0
0
[ ]1
17
[ ] 2 or more 29
In your house, was your stove gas or electric? (5)
Response
Points
[ ] Not gas or electric 0
[ ] Yes gas or electric 20
If it was not gas or electric, what type of stove was it? ______________
If you used wood, for how long? ________________
Thinking about the person that was the major income earner for the house, what was the highest
level of school that he/she completed? (5)
Response
Points
[ ] No studies
0
Table of points per level:
[ ] Primary incomplete
0
Level
Points
[ ] Primary completed
22
E
Until 60
[ ] Middle school incomplete 22
D
61-101
D+
102-156
[ ] Middle school complete
22
C
157-191
[ ] Commercial degree
38
C+
192-241
[ ] Technical degree
38
A/B
242 and more
[ ] High school incomplete
38
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[
[
[
[
[
[

] High school complete
] Bachelors incomplete
] Bachelors complete
] Specialist, Masters degree
] Doctoral degree
] Don’t know /no answer

38
52
52
72
72

Research calculated AMAI SES:
______ Total Points
______ Final Level

How many people were living with you- including kids and adults? _________
How many rooms in the house were used to sleep? _________ rooms to sleep (1)
How often did you go to sleep feeling hungry because there wasn’t food?
[ ] Never
[ ] Sometimes (1-3 nights/wk)
[ ] Frequently (4-6 nights/wk)
Every night

[ ]

TB HISTORY

[Cross-validated with clinical records]
At any time have you received the skin test for tuberculosis (PPD)?
[ ] Yes
[ ] No
[ ] Don’t know
Date of application of PPD: ______________ (mm/dd/yr)
Date of reading of PPD: ______________ (mm/dd/yr)
Result: [ ] Positive

[ ] Negative

[ ] Don’t know

At any time, have you be given a vaccine- BCG- en the arm against tuberculosis? (the one that
leaves a scar) (1)?
[ ] Yes
[ ] No
[ ] Don’t know
Do you have a scar on your arm (right or left)? [ ] Yes [ ] No [ ] Don’t know
Have you had close contact (e.g., lived) with anyone who is/was sick with tuberculosis?
[ ] YES
[ ] NO [ ] Don’t know
If “yes,” when? __________ (year) or

___________ (age)

Is there anyone in your family that has or has had tuberculosis? (12)
[ ] Yes
[ ] No
[ ] Don’t know
If “yes,” who? _____________________________________________________
Have you ever had to take medications for tuberculosis?
[ ] YES
[ ] NO [ ] Don’t know
If “YES,” how many months were you on the tuberculosis medications? ______
How many pills did you take per day? ____________
Did you completely finish your treatment? [ ] YES
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[ ] NO

[ ] Don’t know

If “No,” why not?
[ ] Transportation to the clinic was difficult
[ ] I felt bad when I took them
[ ] The clinic did not have the medications
[ ] I forgot to take them
[ ] There were too many medications to take in one day
[ ] I didn’t understand why I was taking them
[ ] Other reasons: _______________________________________________________

Date of initiation of treatment: ________________ (month/yr)
Date of end of treatment: ___________________ (month/yr)
Besides those medications from the doctor for tuberculosis, have you used other medicines or
tried other things for the treatment of tuberculosis- for example, natural therapies or medicines,
herbs?
[ ] Yes
[ ] No
[ ] Don’t know
If “yes,” what else have you used or tried?
____________________________________________
How is tuberculosis spread from one person to another, in your opinion? CHECK ALL THAT
APPLY: (4)
[ ] Through the air by coughing or sneezing
[ ] Working too much
[ ] Through sharing utensils
[ ] Cold weather
[ ] Sharing towels
[ ] Malnutrition
[ ] Through touching a person with tuberculosis [ ] Sharing food
[ ] Through sexual contact
[ ] Through mosquito bites
[ ] From the genes of the parents
[ ] By the mind
[ ] Supernatural
[ ] Other: ___________________________
[ ] Don’t know
Do you believe that tuberculosis has a cure? (4)
[ ] Yes
[ ] No
[ ] Don’t know
If a member of your family got tuberculosis, would you want it to remain a secret or not? (4)
[ ] Yes, remain a secret
[ ] No
[ ] Don’t know/depends on : __________________________________________
Have you felt any discrimination in your community because you have tuberculosis?
[ ] Yes
[ ] No
[ ] Don’t know
If “yes,” what types of discrimination?
Do you have any fears in relation to tuberculosis?
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[ ] Yes

[ ] No

[ ] Don’t know

If “yes,” what fears do you have?
How did you learn about tuberculosis?
[ ] Clinic, hospital
[ ] Family, friends
[ ] Radio
[ ] Internet

[
[
[
[

] Doctors
] TV, movies
] Magazines, newspapers
] Other sources: __________________________

HEALTH PROFILE

[Cross-validate from clinical records]
(For Women) Are you currently pregnant? [ ] Yes
[ ] No
[ ] Don’t know
If “YES,” how many weeks are you in the pregnancy? ________ weeks
Do you currently smoke cigarettes or use tobacco?

[ ] YES

[ ] NO

How many cigarettes do you
usually smoke in one day? _________
How many years have you smoked?
___________ years

Have you smoked >100
cigarettes in your life?

[ ] Yes
[ ] No
Research calculated Pack Years:
(#cigarettes per day * years of
smoking)/20
( _____ * ____ ) / 20
______ Final Pack Years

When did you stop smoking?

Go to the next
question

[ ] Longer than three years ago
[ ] In the past three years

How many did you used to smoke a day?
______ each day
How many years did you smoke?
______ years
What (other) type of tobacco do you currently use, if any? (2)
[ ] None
[ ] Pipe
[ ] Chewing tobacco
[ ] Snuff
[ ] Cigars
[ ] Other: _____________________________
Are you around cigarette smoke even if you're not smoking? For example, is there anyone in your
house that smokes?
[ ] YES
[ ] NO
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If “YES,” where? ______________________________________
If “YES,” how many hours are you around it? _____ hrs/day
_____ hrs/week
Do you drink alcohol? [ ] Yes

[ ] No

If “yes,” please respond to the following questions:
When you drink, what do you drink? _____________________________
When you drink ___________________, how much do you drink? _______________________
With what frequency do you drink? _____ times/day
_____times/month

_____ times/week

Do you have or have you ever had any medical conditions or problems that require some
treatment? (7; 8)
[ ] YES [ ] NO
If “YES,” check all that apply:
[ ] Hypertension (high blood pressure)

[ ] Depression

[ ] Diabetes: [ ] Gestational [ ] Type I [ ] Type II

[ ] Rheumatoid arthritis

[ ] Crohn’s disease

[ ] Kidney disease

[ ] Thyroid disorder

[ ] Worms, helminths

[ ] Asthma

[ ] Heart disease

[ ] Cancer: __________________

[ ] Hepatitis

[ ] Silicosis

[ ] Malnutrition

[ ] Alcoholism

[ ] HIV or AIDS

[ ] Organ transplant: _______________
________________

[ ] Other(s):

Co-morbidities from the patient’s medical record:
_______________________________
_____________________________
_______________________________
_____________________________
_______________________________
_____________________________
Do you take a vitamin, multivitamin, or mineral supplement regularly (4+ times per week), for
example, iron, calcium, folic acid, etc.?
[ ] YES
[ ] NO
If “YES,” what vitamin and/or mineral supplement?
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Single nutrient: ____________________
Multivitamin: _____________________
Single mineral: ____________________
When did you begin using the vitamin(s) and/or mineral supplements? ___________
(mm/yy)
Out of the past 7 days, how many days did you actually take them? _______ days
How often do you eat:
Food

Never or a few
times a year

Each month
(monthly)

Each week
(weekly)

Every day
(daily)

Fruit
Vegetables
Red meat
Poultry
Fish
How often do you go to sleep feeling hungry because there wasn’t food?
[ ] Never
[ ] Sometimes (1-3 nights/wk)
[ ] Frequently (4-6 nights/wk)
Every night

[ ]

Have you ever been a resident, employee, or volunteer at: [CHECK ALL THAT APPLY]
[ ] Prison- [ ] never [ ] resident [ ] employee [ ] volunteer; time of stay: _________
[ ] Nursing home- [ ] never [ ] resident [ ] employee [ ] volunteer; time of stay:
_________
[ ] Homeless shelter- [ ] never [ ] resident [ ] employee [ ] volunteer; time of stay:
________
Have you ever taken any recreational drugs?

[ ] YES

[ ] NO

If “yes,” have you ever used a drug by injecting it with a needle/syringe? [ ] YES
If “YES” to drug use, complete:
Check if taken:
[ ] Marijuana/Hashish:

[ ] How long have you used this? __________

[ ] Heroin:

[ ] How long have you used this? __________

[ ] Cocaine/Crack:

[ ] How long have you used this? __________

[ ] Inhalants (glue, solvent):

[ ] How long have you used this? __________

[ ] Methamphetamines:

[ ] How long have you used this? __________

[ ] Other: ____________

[ ] How long have you used this? __________

[ ] Other: ____________

[ ] How long have you used this? __________
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[ ] NO

Height: ________ cm
(Conversion to feet: ________ft)

Weight: _________ kg
(Conversion to pounds: ________lbs)

Researcher calculated BMI: ______
(Source: www.cdc.gov)
Mexican classification: _______________________
(NORMA MX 2005)
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